Szanowni Państwo, informujemy, że w puli organizatorów pozostały jeszcze wolne pokoje hotelowe.

Zainteresowanych prosimy o kontakt pod adresem ptk2015@casusMEDICAL.pl

Invitation

Dear Sirs, Colleagues,

we are pleased that the XX Jubilee PCS Congress - the most important scientific and educational meeting for cardiologists in Poland is held in Poznań again. 

On behalf of the Organizing Committee it is our great pleasure to invite you to the capital of the Great Poland Region again to participate in the

XX International Congress of the Polish Cardiac Society,

which takes place on September 15-17, 2016

For the twentieth time, we are going to face challenges of contemporary medicine and raise the most significant issues related to cardiology. We hope each participant will have an opportunity to review the latest scientific research, recommendations and diagnostic methods as well as achievements in cardiology, cardiac surgery and related fields.  

The Jubilee constitutes an excellent opportunity to rethink and summarise the progress of the medical field in which we are proudly involved for the patients’ good.

Congresses of the Polish Cardiac Society are primarily characterized by reach scientific program, however, we are aware that the venue of the event is of great importance, as well. Therefore, we warmly invite you to the capital of the Great Poland Region. 

 

Romuald Ochotny, Przemysław Mitkowski

The Chairman of the Organizing Committee of the XX International Congress of the Polish Cardiac Society

Komitet naukowy

Komitet Naukowy

Dariusz Dudek (Kraków) – Przewodniczący KNK
Piotr Ponikowski (Wrocław) – Prezes-Elekt PTK
Jarosław Kaźmierczak (Szczecin) – Konsultant krajowy ds. kardiologii
Krzysztof J. Filipiak (Warszawa) – Redaktor Naczelny "Kardiologii Polskiej"
Andrzej Budaj (Warszawa) – Przewodniczący Komisji Wytycznych i Szkolenia

Skład członków tworzących grupy tematyczne:

Michał Krejca (Katowice)
Jacek Legutko (Kraków)
Radosław Parma (Katowice)
Beata Średniawa (Zabrze)
Andrzej Beręsewicz (Warszawa)
Małgorzata Kurpesa (Łódź)
Katarzyna Bieganowska (Warszawa)
Rafał Baranowski (Warszawa)
Przemysław Mitkowski (Poznań)
Grażyna Brzezińska-Rajszys (Warszawa)
Monika Komar (Kraków)
Jarosław D. Kasprzak (Łódź)

Piotr Lipiec (Łódź)
Magdalena Kostkiewicz (Kraków)
Mirosław Kowalski (Warszawa)
Ewa Jankowska (Wrocław)
Jadwiga Nessler (Kraków)
Marcin Kurzyna (Otwock)
Karol Kamiński (Białystok)
Ryszard Piotrowicz (Warszawa)
Grzegorz Kopeć (Kraków)
Tomasz Zdrojewski (Gdańsk)
Andrzej Januszewicz (Warszawa)
Izabela Uchmanowicz (Wrocław)
Dorota Krówczyńska (Warszawa)
Sekretarz KNK PTK: Zbigniew Siudak

Komitet organizacyjny

Komitet organizacyjny

Romuald Ochotny

Przemysław Mitkowski

 

Programme

ostatnia aktualizacja 2016-08-30 02:50

Thursday

15

September
SALA 1 SALA 2 SALA 3 SALA 4 SALA 5 SALA 6 SALA 7 SALA 8 SALA 9 SALA 10 SALA 11 SALA 12 SALA 13 SALA Sesje plakatowe
09:00 - 10:30

Heart failure in women – how to prevent, how to treat?

Heart failure in women – how to prevent, how to treat?

Session of the PCS Working Group on Women Heart Diseases

Chairpersons: M. Klocek (Kraków)
Chairpersons: A. Fijałkowska (Warszawa)

Heart failure with preserved ejection fraction – a new insight
K. Łoboz-Grudzień (Wrocław)

How to prevent the development of heart failure after a heart attack?
Z. Kornacewicz-Jach (Szczecin)

Drug treatment of heart failure in women – how to improve prognosis?
M. Janion (Kielce)

Implantable devices in heart failure – are also effective in women?
B. Małecka (Kraków)

Who should undergo minimally invasive surgery and for whom a conventional surgery is better option?

Who should undergo minimally invasive surgery and for whom a conventional surgery is better option?

Session of the PCS Working Group on Cardiac Surgery

Chairpersons: M. Jemielity (Poznań)
Chairpersons: L. Anisimowicz (Bydgoszcz)

Coronary heart disease: for whom is CCABG, OPCAB, MIDCAB, TECAB?
M. Cisowski (Bielsko-Biała)

Mitral valve surgery: conventional vs. minimally invasive. Advantages and disadvantages
T. Hirnle (Białystok)

Who should undergo atrial fibrillation ablation and left atrial appendage closure with minimally invasive method and for whom conventional method is better
P. Suwalski (Warszawa)

Invasive cardiology in the prevention and treatment of stroke

Invasive cardiology in the prevention and treatment of stroke

Session of the PCS Association of Cardiovascular Interventions

Chairpersons: J. Legutko (Kraków)
Chairpersons: W. Wojakowski (Katowice)
Chairpersons: A. Ochała (Katowice)
Discussion panel: D. Dudek (Kraków)
Discussion panel: M. Lesiak (Poznań)
Discussion panel: A. Witkowski (Warszawa)
Discussion panel: R. Gil (Warszawa)
Discussion panel: M. Gąsior (Zabrze)
Discussion panel: S. Dobrzycki (Białystok)
Discussion panel: Z. Chmielak (Warszawa)
Discussion panel: T. Pawłowski (Warszawa)

The latest achievements in prevention and treatment of cardiovascular stroke – neurologist perspective
A. Kobayashi (Warszawa)

Asymptomatic and symptomatic patient with significant carotid artery stenosis – conservative treatment, endarterectomy or stent?
P. Pieniążek (Kraków)

Patient with patent foramen ovale – when do we need to close the defect?
M. Demkow (Warszawa)

Patient with atrial fibrillation – when do we need to eliminate left atrial appendage?
M. Grygier (Poznań)

Stroke as a complication of the invasive cardiology procedure – is it possible to prevent it?
R. Parma (Katowice)

Interventional treatment of the ischemic stroke – is it time to cross the next frontier?
S. Bartuś (Kraków)

Panel discussion: invasive cardiologist's present and future role in multidisciplinary teams in the prevention and treatment of stroke

Acute heart failure – crucial first 24 hours in Intensive Cardiac Care Unit

Acute heart failure – crucial first 24 hours in Intensive Cardiac Care Unit

Session of the PCS Working Group on Acute Cardiac Care and Resuscitation

Chairpersons: B. Średniawa (Zabrze)
Comment: W. Banasiak (Wrocław)
Comment: Z. Gąsior (Katowice)

Pitfalls of laboratory diagnostics
A. Tycińska (Białystok)

The role of echocardiography – look not only into the heart
B. Sobkowicz (Białystok)

Indications and limitations of modern imaging techniques in acute cardiac care patients
I. Michałowska (Warszawa)

Invasive diagnostic procedures – when to use it
M. Gierlotka (Zabrze)

Ventricular arrhythmia – important questions

Ventricular arrhythmia – important questions

Session of the PCS Working Group on Noninvasive Electrocardiology and Telemedicine

Chairpersons: I. Cygankiewicz (Łódź)
Chairpersons: M. Kurpesa (Łódź)

Are you sure it is ventricular? Differentiation of arrhythmias
D. Wojciechowski (Warszawa)

Does ventricular always mean dangerous?
P. Ptaszyński (Łódź)

Is drug treatment of ventricular arrhythmias obsolete? YES!
S. Stec (Warszawa)

Is drug treatment of ventricular arrhythmias obsolete? NO!
K. Szydło (Katowice)

How to evaluate the global risk in cardiovascular diseases prevention?

How to evaluate the global risk in cardiovascular diseases prevention?

Session of the PCS Working Group on Prevention and Epidemiology

Chairpersons: W. Drygas (Warszawa)
Chairpersons: R. Topór-Mądry (Kraków)

New version of global risk estimation and SCORE for Polish population
T. Zdrojewski (Gdańsk, Warszawa)

Ideal Cardiovascular Health: theoretical frame and practical aplication in WOBASZ Study
W. Drygas (Warszawa)

Is the present method of global risk estimation and SCORE optimal for Poland?
A. Pająk (Kraków)

Valvular heart disease – what is new in 2016?

Valvular heart disease – what is new in 2016?

Session of the PCS Working Group on Congenial and Valvular Heart Disease

Chairpersons: M. Komar (Kraków)
Chairpersons: P. Szymański (Warszawa)
Chairpersons: K. Mizia-Stec (Katowice)

Aortic valve
T. Hryniewiecki (Warszawa)

Mitral valve
A. Gackowski (Kraków)

Tricuspid valve
J. Kasprzak (Łódź)

Rigth-sided heart failure in left ventricular heart diseases

Rigth-sided heart failure in left ventricular heart diseases

Session of the PCS Working Group on Heart Failure

Chairpersons: E. Straburzyńska-Migaj (Poznań)
Chairpersons: J. Nessler (Kraków)
Chairpersons: P. Ponikowski (Wrocław)

Pathophysiology of the right ventricle and pulmonary circulation
K. Kamiński (Białystok)

Evaluation of the right ventricle
Z. Oko-Sarnowska (Poznań)

Right-sided heart failure as prognostic factor
M. Gruchała (Gdańsk)

Management of right-sided heart failure – pharmacotherapy? mechanical support?
M. Zakliczyński (Zabrze)

Systemic right ventricle – what do we know?

Systemic right ventricle – what do we know?

Session of the PCS Working Group on Adult and Adolescent Congenital Heart Diseases

Chairpersons: A. Klisiewicz (Warszawa)
Chairpersons: G. Brzezińska-Rajszys (Warszawa)

Embryologic development and anatomy of the right ventricle – different, but is it worse?
A. Koleśnik (Warszawa)

The natural history of the systemic right ventricle – what do we really know?
O. Trojnarska (Poznań)

How to assess the function of systemic right ventricle?
E. Kowalik (Warszawa)

The systemic right ventricle failure – how to manage?
M. Lipczyńska (Warszawa)

Acute coronary syndrome

Acute coronary syndrome

Session of the PCS Working Group on Nursing and Medical Technique

Chairpersons: M. Wolszczak (Warszawa)
Chairpersons: Z. Kamińska (Warszawa)

How to diagnose?
P. Hetman (Kraków)

How to treat?
D. Krówczyńska (Warszawa)

How to live after?
I. Młynarczyk (Zabrze)

Controversies in the European Society of Cardiology guidelines. How they are procured by experts who prepare questions for state examination in Cardiology?

Controversies in the European Society of Cardiology guidelines. How they are procured by experts who prepare questions for state examination in Cardiology?

The joint session of the Club 30 and the National Consultant in cardiology

Chairpersons: J. Kaźmierczak (Szczecin)
Chairpersons: G. Kopeć (Kraków)
Chairpersons: P. Burchardt (Poznań)

Antithrombotic treatment (double antiplatelet therapy and triple antithrombotic therapy) in the context of proper preparation for various invasive procedures
J. Baran (Warszawa)

Antithrombotic treatment in stroke – summary of cardiological and neurological guidelines
K. Kupczyńska (Łódź)

When, in whom and what treatment for patients with ACS and heart failure
M. Haberka (Katowice)

When and whom left ventricle assist should be considered during ACS and cardiac shock – the differences in indications for IABP and left ventricle assist device
M. Wybraniec (Katowice)

Hypertension – different target values for different patients. Who will benefit from the ASA use in hypertension?
F. Szymański (Warszawa)

Prevention of AKI – discrepancies in guidelines issued in the same year
Ł. Krzych (Zabrze)

10:45 - 12:15

The biggest challenges in cardiac rehabilitation in 2016. Different approaches, common goal

The biggest challenges in cardiac rehabilitation in 2016. Different approaches, common goal

Session of the PCS Working Group on Cardiac Rehabilitation and Exercise Physiology

Chairpersons: R. Piotrowicz (Warszawa)
Chairpersons: Z. Eysymontt (Ustroń)

Rehabilitation after myocardial infarction – necessity and appropriate completion of treatment
P. Buszman (Katowice)

Rehabilitation after myocardial infarction – it is not enough! Patient education is equally important – Schools of the Heart
D. Dudek (Kraków)

High-risk cardiac surgery – today’s expectations of rehabilitation
K. Widenka (Rzeszów)

Rehabilitation after high-risk cardiac surgeries – necessity and a difficult challenge
A. Wilczek-Banc (Katowice)

Patient with heart failure – hybrid cardiac rehabilitation, direction of the future
E. Piotrowicz (Warszawa)

Patient with heart failure – rehabilitation is not enough
E. Straburzyńska-Migaj (Poznań)

Controversies in the treatment of acute pulmonary embolism

Controversies in the treatment of acute pulmonary embolism

Session of the PCS Working Group on Pulmonary Circulation

Chairpersons: M. Ciurzyński (Warszawa)
Chairpersons: G. Kopeć (Kraków)

Do NOAC replace vitamin K antagonists in the treatment of venous thromboembolism?
Pro: P. Błaszczak (Lublin)
Contra: M. Kostrubiec (Warszawa)

Bleeding in patients with acute pulmonary embolism treated with NOAC – a clinically serious problem
Pro: M. Kurzyna (Otwock)
Contra: A. Tomaszuk-Kazberuk (Białystok)

General Assembly of the Members of PCS Association Group on Cardiovascular Interventions

General Assembly of the Members of PCS Association Group on Cardiovascular Interventions

Problems of sport cardiology – sport, law, medicine

Problems of sport cardiology – sport, law, medicine

Session of the PCS Working Group on Sports Cardiology

Chairpersons: H. Krysztofiak (Warszawa)
Chairpersons: R. Główczyńska (Warszawa)

Doping in sport – definitions, resources, methods, procedures
A. Pokrywka (Warszawa)

Cardiological complications resulting from using doping in sport
R. Główczyńska (Warszawa)

Cardiological screening of young athletes
A. Turska-Kmieć (Warszawa)

Certification in sport medicine – legal aspects and dilemmas
H. Krysztofiak (Warszawa)

Modern cardiovascular imaging in cardiology practice

Modern cardiovascular imaging in cardiology practice

Session of the PCS Working Group on Cardiac Magnetic Resonance Imaging and Computed Tomography

Chairpersons: M. Kruk (Warszawa)
Chairpersons: K. Miszalski-Jamka (Zabrze)

Cardiac computed tomography – translating research into clinical practice
C. Kępka (Warszawa)

Cardiac MR imaging – current status and future directions
K. Miszalski-Jamka (Zabrze)

Fusion, hybrid, and multimodality imaging in cardiovascular diagnostics and interventions
M. Kruk (Warszawa)

New horizons in cardioprotection – whether or not and what to use aside from essential medications?

New horizons in cardioprotection – whether or not and what to use aside from essential medications?

Session of the PCS Working Group on Cardiovascular Pharmacotherapy

Chairpersons: A. Mamcarz (Warszawa)
Chairpersons: B. Wożakowska-Kapłon (Kielce)

Carnitine
A. Mamcarz (Warszawa)

Coenzyme Q10
K. Filipiak (Warszawa)

Ranolazine
B. Wożakowska-Kapłon (Kielce)

Vitamin D
F. Szymański (Warszawa)

Trimetazidine
M. Barylski (Łódź)

Silent atrial fibrillation – silent killer. Section of Heart Rhythm of the Polish Cardiac Society initiative „Take the pulse and prevent a stroke”

Silent atrial fibrillation – silent killer. Section of Heart Rhythm of the Polish Cardiac Society initiative „Take the pulse and prevent a stroke”

Session of the PCS Working Group on Heart Rhythm

Chairpersons: J. Kaźmierczak (Szczecin)
Chairpersons: O. Kowalski (Zabrze)
Chairpersons: M. Sterliński (Warszawa)

Silent atrial fibrillation – epidemiology and threats
A. Fuglewicz (Wrocław)

Neurological consequences of silent atrial fibrillation
. TBD

By all means... Diagnostics for silent atrial fibrillation
K. Szydło (Katowice)

Pharmacological and non-pharmacological silent atrial fibrillation treatment
Ł. Szumowski (Warszawa)

Can expensive methods turn out to be the cheapest? Selected insights of pharmacoeconomics into silent atrial fibrillation management
M. Farkowski (Warszawa)

Echocardiographic examination of an adult patient with congenital heart disease

Echocardiographic examination of an adult patient with congenital heart disease

Session of the PCS Working Group on Echocardiography

Chairpersons: P. Lipiec (Łódź)
Chairpersons: O. Trojnarska (Poznań)
Chairpersons: A. Szyszka (Poznań)

Protocol of echocardiographic examination of an adult patient with congenital heart disease
P. Szymański (Warszawa)

Congenital defects of LVOT, aortic valve and aorta
M. Fijałkowski (Gdańsk)

Ventricular and atrial septal defect. Patent ductus arteriosus
K. Mizia-Stec (Katowice)

Tetralogy of Fallot. Ebstein’s anomaly
A. Gackowski (Kraków)

Transposition of great arteries. The Fontan circulation
O. Trojnarska (Poznań)

Transcatheter closure of ventricular septal defects – old problems, new possibilities

Transcatheter closure of ventricular septal defects – old problems, new possibilities

Session of the PCS Working Group on Pediatric Cardiology

Expert: R. Przybylski (Zabrze)
Expert: M. Szkutnik (Zabrze)
Chairpersons: G. Brzezińska-Rajszys (Warszawa)

New possibilities in transcatheter closure of congenital, perimembranous VSD
J. Białkowski (Zabrze)

Transcatheter closure of Gerbode VSD – multicenter study
G. Smolka (Katowice)

Transcatheter closure of postinfarction VSD
M. Demkow (Warszawa)

Transcather VSD closure with PFM coils – multicenter study
R. Sabiniewicz (Gdańsk)

Hybrid, periventricular closure of muscular VSD
M. Chojnicki (Gdańsk)

Cardiac infarction and stroke – two faces of the same disease!

Cardiac infarction and stroke – two faces of the same disease!

Session of the PCS Working Group on Experimental Cardiology

Chairpersons: M. Kurpisz (Poznań)
Chairpersons: A. Beręsewicz (Warszawa)

Introduction to the system of haemostasis
E. Chabielska (Białystok)

Cryptogenic strokes – crosstalk with the heart
A. Członkowska (Warszawa)

Ischaemic stroke in a patient with the history of cardiac infarction – from pathophisiology to the therapy
A. Undas (Kraków)

Cardiac infarction – crosstalk with the brain
A. Cudnoch-Jędrzejewska (Warszawa)

Cardiac infarction – new forms of antiplatelet and antithrombotic therapy
Z. Huczek (Warszawa)

Nuclear cardiology in special populations

Nuclear cardiology in special populations

Session of the PCS Working Group on Nuclear Cardiology

Chairpersons: M. Kostkiewicz (Kraków)
Chairpersons: M. Dziuk (Warszawa)

Nuclear imaging in patients with infective endocarditis
W. Szot (Kraków)

Nuclear cardiology in women with suspected coronary artery disease
A. Kaźmierczak-Dziuk (Warszawa)

Nuclear imaging in patients with hypertension
A. Stańczyk (Warszawa)

Imaging in patients after coronary revascularization
L. Gryszko (Warszawa)

12:30 - 14:00

Modern cardiological pharmacotherapy – when, with whom and why?

Modern cardiological pharmacotherapy – when, with whom and why?

Satellite session organized by Biofarm

Lacidipine
A. Tykarski (Poznań)

Nebiwolol
A. Szyszka (Poznań)

Torasemide
M. Barylski (Łódź)

Evolocumab – new perspectives in the treatment of lipid disorders

Evolocumab – new perspectives in the treatment of lipid disorders

Satellite session organized by AMGEN

Chairpersons: P. Ponikowski (Wrocław)

The landscape of hypercholesterolemia in the face of new ESC guidelines
G. Opolski (Warszawa)

The role of PCSK9 inhibitors in the treatment of hypercholesterolemia – Evolocumab
Z. Kalarus (Zabrze)

Patients who don't achieve recommended LDL-C targets. May Evolocumab solve the problem? – case study
Z. Gaciong (Warszawa)

Cardiac contractility modulation (CCM) – nonexcitatory electrical stimulation of the heart in the therapy of chronic heart failure

Cardiac contractility modulation (CCM) – nonexcitatory electrical stimulation of the heart in the therapy of chronic heart failure

Satellite session organized by IMPULSE-DYNAMICS

Chairpersons: P. Ptaszyński (Łódź)

CCM – pathophysiological background and clinical results of the therapy
J. Kuschyk (Mannheim)

Therapy of chronic heart failure with CCM in own experience
D. Jagielski (Wrocław)

Therapy of chronic heart failure with CCM in own experience
K. Kaczmarek (Łódź)

Discussion

Session of original articles nominated for the prize of the PCS Scientific Committee – basic sciences

Session of original articles nominated for the prize of the PCS Scientific Committee – basic sciences

Jury: A. Beręsewicz (Warszawa)
Jury: K. Filipiak (Warszawa)
Jury: T. Guzik (Kraków)
Jury: M. Kurpisz (Poznań)
Jury: A. Undas (Kraków)

Interactions of antazoline with human ether-à-go-go-related gene channels
B. Badyra (Kraków)

Diagnostic value of free circulating microRNAs' panel (miR1, miR-133a, miR-208a, miR-499) in differentiation of clinical types of coronary disease: acute myocardial infarction without ST segment elevation, unstable angina and stable coronary artery disease
D. Miśkowiec (Łódź)

The variability of the atrioventricular conduction has asymmetrical features
B. Żuchowski (Poznań)

The effect of high-fat meal on the barrier functions and inflammatory status of human vascular endothelial cells
P. Gorzelak (Łódź)

Comparison of endomyocardial biopsy results between early and late dilated cardiomyopathy
P. Rubiś (Kraków)

Session of original articles nominated for the prize of the PCS Scientific Committee – clinical sciences

Session of original articles nominated for the prize of the PCS Scientific Committee – clinical sciences

Jury: W. Wojakowski (Katowice)
Jury: T. Hryniewiecki (Warszawa)
Jury: K. Kamiński (Białystok)
Jury: D. Dudek (Kraków)
Jury: J. Drożdż (Łódź)

Transcatheter closure of paravalvular leaks using a Paravalvular Leak Device (PLD) – a prospective Polish registry
G. Smolka (Katowice)

Trends in prevention after a myocardial infarction in patients with reduced left ventricle ejection fraction in Poland
M. Gąsior (Zabrze)

Improvement of mitral regurgitation predicts response to cardiac resynchronization therapy
A. Leopold-Jadczyk (Zabrze)

Changing of the balloon pulmonary angioplasty strategy resulted in reduced complication ratio and mortality
S. Darocha (Otwock)

Temporal trends in treatment and outcomes of patients with NSTEMI and STEMI in Poland in years 2009–2013 – analysis of AMI-PL registry
M. Gierlotka (Zabrze)

Session of original articles nominated for the prize of the PCS Scientific Committee – students' articles

Session of original articles nominated for the prize of the PCS Scientific Committee – students' articles

Jury: Z. Siudak (Kraków)
Jury: P. Burchardt (Poznań)

Patterns of antithrombotic therapy in patients with atrial fibrillation in tertiary cardiology centre and general hospital in Belarus: still too far from the guidelines
E. Surmacz (Grodno)

Prevalence of dietary supplements and over-the-counter drug use in patients with arterial hypertension
M. Stopa (Kraków)

Stress cardiomyopathy and coronary artery disease – contrary or complementary? A new look at the differential diagnosis of takotsubo syndrome
B. Kołodziejczyk (Kraków)

Septal pouch – morphology and imaging methods
M. Hołda (Kraków)

Accuracy of electrocardiographic criteria for left ventricular hypertrophy in patients with aortic valve stenosis
K. Bula (Katowice)

Students’ articles awarded at National Conferences for Students

Students’ articles awarded at National Conferences for Students

Prace studenckie

Jury: A. Dziewierz (Kraków)
Jury: B. Michalski (Łódź)
Jury: E. Jankowska (Wrocław)
Jury: M. Grabowski (Warszawa)

The article awarded at International Medical Congress of Silesia 2016 in Katowice: Accuracy of electrocardiographic criteria for left ventricular hypertrophy in patients with aortic stenosis
M. Sejud (Katowice)

The article awarded at XXX National Cardiology Conference for Students in Gdansk: The platelet-to-lymphocyte ratio (PLR) and neutrophil-to-lymphocyte ratio (NLR) – evaluation and comparison of prognostic indices in patients with heart failure
Z. Kułaczkowska (Zabrze)

The article awarded at 11th Bialystok International Medical Congress for Young Scientists in Bialystok: Similar clinical and echocardiographic outcomes of cardiac resynchronization therapy irrespectively to presence of left bundle branch block – insights from single-centre registry
K. Derbisz (Katowice)

The article awarded at 54th Polish and 12th International Conference „Juvenes Pro Medicina” in Lodz: 10-year risk of atrial fibrillation in patients hospitalized in the Department of Cardiology
P. Łęczycki (Łódź)

The article awarded at 12th Warsaw International Medical Congress for Young Scientists in Warsaw: Evaluation of cardiac risk stratification tools in major vascular surgeries
J. Fronczek

The article awarded at XI International Students' Conference on Cardiology in Zabrze: Early and long-term complications in more than one thousand recipients of implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillators – insights from Silesian Center for Heart Diseases Defibrillator Registry
K. Towarek (Zabrze)

Poster session of articles nominated for the prize of the PCS Scientific Committee

Poster session of articles nominated for the prize of the PCS Scientific Committee

Jury: M. Kurzyna (Otwock)
Jury: A. Gackowski (Kraków)
Jury: M. Janion (Kielce)
Jury: O. Kowalski (Zabrze)
Jury: J. Kasprzak (Łódź)

ECG patterns are different in fibrosis positive and negative dilated cardiomyopathy patients
P. Rubiś (Kraków)

Human aortic valve interstitial cells express coagulation factors: the impact of inflammatory stimulation
E. Wypasek (Kraków)

The outcome of percutaneous procedures for symptomatic subclavian artery occlusive disease. The registry of the John Paul II Hospital in Krakow
T. Przewłocki (Kraków)

Lead-dependent venous occlusion; effectiveness of ipsilateral arteriovenous fistula for hemodialysis. Findings from 1633 preoperative venograms
M. Czajkowski (Lublin)

Remote monitoring improves long-term prognosis in heart failure patients with implantable cardioverter-defibrillators in real-life
A. Kurek (Zabrze)

The left atrial appendage morphology correlates with stroke risk in patients with sinus rhythm
M. Komar (Kraków)

Coronary artery computed tomography as the first-choice imaging diagnostics in patients with high probability of coronary artery disease – preliminary results of CAT-CAD study
P. Rudziński (Warszawa)

Novel prognostic value of combined echocardiography parameters compared to measurements acquired by right heart catheterization in patients with severe systolic heart failure within a year of observation
W. Gilewski (Bydgoszcz)

The influence of air pollution on the occurrence and decompensation of cardiovascular diseases and mortality in the population of highly polluted agglomeration
A. Ciślak (Katowice, Zabrze)

Early and 12-month mortality of young women and men with acute myocardial infarction – analysis from PL-ACS registry
A. Gorgoń-Komor (Bielsko-Biała)

14:15 - 15:45 Polish Forum of Science in Cardiac and Vascular Diseases

EORP – the way to know where we are

EORP – the way to know where we are

Chairpersons: P. Hoffman (Warszawa)

The EORP initiative
A. Maggioni (Florencja)

An overview of the EU and Poland EORP findings: HF Long Term
J. Drożdż (Łódź)

An overview of the EU and Poland EORP findings: AF Long Term
M. Mazurek (Zabrze)

An overview of the EU and Poland EORP findings: STEMI ACS
J. Legutko (Kraków)

An overview of the EU and Poland EORP findings: EUROASPIRE IV
A. Pająk (Kraków)

Future perspective
A. Maggioni (Florencja)

General discussion

Hybrid treatment strategies in heart diseases

Hybrid treatment strategies in heart diseases

Session of national consultants (the Heart Team session)

Chairpersons: G. Opolski (Warszawa)
Chairpersons: M. Zembala (Zabrze)

Hybrid treatment of multivessel coronary disease – in whom and how? – Cardiologist
M. Gąsior (Zabrze)

Hybrid treatment of multivessel coronary disease – in whom and how? – Cardiac Surgeon
M. Zembala (Zabrze)

„Best of two worlds” in the hybrid treatment of arrhythmias – Cardiologist
S. Stec (Warszawa)

„Best of two worlds” in the hybrid treatment of arrhythmias – Cardiac Surgeon
P. Suwalski (Warszawa)

TAVI – valid option for high risk patients with symptomatic aortic stenosis – Cardiologist
J. Trębacz (Kraków)

TAVI – valid option for high risk patients with symptomatic aortic stenosis – Cardiac Surgeon
P. Olszówka (Rzeszów)

Role of Hybrid Approach using minimally invasive valve surgery and PCI in complex patients – Cardiologist
R. Gil (Warszawa)

Role of Hybrid Approach using minimally invasive valve surgery and PCI in complex patients – Cardiac Surgeon
R. Sobczyński (Kraków)

Polish Multi-Centre Clinical Trials and Centres: experience and practical conclusions

Polish Multi-Centre Clinical Trials and Centres: experience and practical conclusions

Chairpersons: E. Płońska-Gościniak (Szczecin)
Chairpersons: M. Gierlotka (Zabrze)

ONCOECHO – introduction: left chamber function assessment at rest
M. Kowalski (Warszawa)

ONCOECHO – cardiotoxicity of cancer medications in practice
Z. Gąsior (Katowice)

PolStresECHO – introduction: stress echo of the left chamber function
J. Kasprzak (Łódź)

PolStresECHO – what patient, what stress echo test in practice
E. Płońska-Gościniak (Szczecin)

VIACRT – introduction: basics of qualifications to CRT
T. Kukulski (Zabrze)

VIACRT – the prognosis and the effect of CRT
K. Mizia-Stec (Katowice)

Lipid disorders from doctors’ of various specialisations point of view

Lipid disorders from doctors’ of various specialisations point of view

Chairpersons: J. Kaźmierczak (Szczecin)
Chairpersons: Z. Kalarus (Zabrze)
Chairpersons: W. Drygas (Warszawa)
Discussion panel: M. Banach (Łódź)
Discussion panel: A. Windak (Kraków)

The problem appears in the childhood
A. Brandt (Gdańsk)

The influence of risk factors grows in the adulthood – general internal care
T. Guzik (Kraków)

Consequences in the form of ACS – cardiac care
D. Dudek (Kraków)

Specific situations – patients with familial hypercholesterolemia
M. Gruchała (Gdańsk)

Elderly patients
B. Cybulska (Warszawa)

Discussion: are lipid centres necessary?

Innovations in Polish cardiovascular medicine – will new technologies solve old problems?

Innovations in Polish cardiovascular medicine – will new technologies solve old problems?

Chairpersons: A. Witkowski (Warszawa)
Chairpersons: M. Cisowski (Bielsko-Biała)

Remote monitoring of a cardiac patient – will it improve prognosis and reduce costs?
P. Rozentryt (Zabrze)

Polish technological projects in cardiovascular medicine constitute an opportunity to raise economic competitiveness – biodegradable stents and polymers
P. Buszman (Katowice)

Polish technological projects in cardiovascular medicine constitute an opportunity to raise economic competitiveness – what is new in cardiac surgery?
M. Cisowski (Bielsko-Biała)

Translational and implementation research – it is high time to fill the gap
K. Milewski (Katowice)

Regenerative and cardioprotective therapies – the ups and downs
W. Wojakowski (Katowice)

Organizational innovations necessary to improve prognosis of patients with the history of myocardial infarction
P. Buszman (Katowice)

Revolution in interventional treatment of ischaemic stroke – the role of an Invasive Cardiologist
P. Pieniążek (Kraków)

Interventions in treatment of pulmonary circulation

Interventions in treatment of pulmonary circulation

Chairpersons: A. Araszkiewicz (Poznań)
Chairpersons: M. Kurzyna (Otwock)

Interventional pulmonary artery embolectomy in acute pulmonary embolism
M. Roik (Warszawa)

Surgical treatment of venous thromboembolism (VTE)
A. Biederman (Warszawa)

Balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension
G. Kopeć (Kraków)

Pulmonary artery denervation – new technique to treat pulmonary hypertension?
Ł. Szumowski (Warszawa)

New ESC/PCS guidelines – application in Polish conditions

New ESC/PCS guidelines – application in Polish conditions

Session of the PCS Committee on Guidelines and Education

Chairpersons: A. Fijałkowska (Warszawa)
Chairpersons: A. Budaj (Warszawa)

Diagnosis and treatment of pericardial diseases
K. Mizia-Stec (Katowice)

Diagnosis and treatment of pericardial diseases – commentary
P. Pruszczyk (Warszawa)

Management of acute coronary syndromes without persistent ST segment elevation
L. Poloński (Zabrze)

Management of acute coronary syndromes without persistent ST segment elevation – commentary
A. Dziewierz (Kraków)

Diagnosis and treatment of pulmonary hypertension
Ł. Chrzanowski (Łódź)

Diagnosis and treatment of pulmonary hypertension – commentary
A. Torbicki (Otwock)

Management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
R. Lenarczyk (Zabrze)

Management of patients with ventricular arrhythmias and the prevention of sudden cardiac death – commentary
P. Kułakowski (Warszawa, Rzeszów)

Prevention, diagnosis and treatment of infective endocarditis
W. Kosmala (Wrocław)

Prevention, diagnosis and treatment of infective endocarditis – commentary
J. Stępińska (Warszawa)

16:00 - 17:30

Empagliflozin should be considered in patients with type 2 diabetes in order to prevent or delay the onset of HF and prolong life – ESC guidelines

Empagliflozin should be considered in patients with type 2 diabetes in order to prevent or delay the onset of HF and prolong life – ESC guidelines

Satellite session organized by Boehringer-Ingelheim

Chairpersons: P. Ponikowski (Wrocław)

New opportunities for cardiovascular protection in type 2 diabetes? Learnings from the EMPA-REG OUTCOME® trial
A. Rynkiewicz (Gdańsk)

ESC 2016 guidelines for the diagnosis and treatment of acute and chronic heart failure in patients with type 2 diabetes in the context of empagliflozin
P. Ponikowski (Wrocław)

Empagliflozin – a breakthrough that will change clinical practice?
K. Filipiak (Warszawa)

What is the color of life… Come and decide by yourself...

What is the color of life… Come and decide by yourself...

Satellite session organized by Servier

Chairpersons: J. Stępińska (Warszawa)
Chairpersons: K. Narkiewicz (Gdańsk)

Introduction
J. Stępińska (Warszawa)

Different shades of the therapy – what leads me when making choices – the experts dialogue
A. Tykarski (Poznań), K. Narkiewicz (Gdańsk)

It’s not always colorful… How do I motivate my patients to persist in the therapy?
A. Tomaszuk-Kazberuk (Białystok)

The 20th century was the age of wisdom. The 21st century is ruled by heart and emotions. Discover the colors of your emotions
R. Ohme (Warszawa)

Q & A session
J. Stępińska (Warszawa)

17:45 - 19:15

Conference Opening Ceremony

Conference Opening Ceremony

19:15 - 20:15

The accessibility of modern cardiology and innovations in Poland – the present and the future

The accessibility of modern cardiology and innovations in Poland – the present and the future

Session of the Ministry of Health, the President of PCS, the National Consultant in Cardiology and the Chairperson of the Congress Programme Committee PCS

Chairpersons: P. Hoffman (Warszawa)
Chairpersons: D. Dudek (Kraków)
Discussion panel: K. Radziwiłł (Warszawa)
Discussion panel: J. Pinkas (Warszawa)
Discussion panel: K. Łanda (Warszawa)
Discussion panel: J. Kaźmierczak (Szczecin)

The list of paradoxes related to cardiology and cardiac surgery in the healthcare organization

The condition of cardiology in Poland and the prospects for evaluating and financing of medical services in 2017

Scientific research and innovations in Polish cardiology – how to ensure progress

20:30 GET TOGETHER
Friday

16

September
SALA 1 SALA 2 SALA 3 SALA 4 SALA 5 SALA 6 SALA 7 SALA 8 SALA 9 SALA 10 SALA 11 SALA 12 SALA 13 SALA Sesje plakatowe
09:00 - 10:30

Cardiac patient – just cardiac? Nursing care aspects

Cardiac patient – just cardiac? Nursing care aspects

Chairpersons: D. Krówczyńska (Warszawa)
Chairpersons: A. Młynarska (Katowice)
Chairpersons: A. Serafin (Warszawa)

Patient with acute kidney failure
M. Kmiecicka (Warszawa)

Patient with diabetes and metabolic syndrome
A. Walendziak (Skierniewice)

Patient with neurologic complications
A. Kabat (Łęczyca)

Cancer patient
A. Młynarska (Katowice)

Patient with hemorrhagic complications
K. Czapla (Zabrze)

Elderly patient
M. Walkiewicz (Warszawa)

New challenges of cardiology. Who should be rehabilitated?

New challenges of cardiology. Who should be rehabilitated?

Chairpersons: D. Szalewska (Gdańsk)
Chairpersons: J. Wolszakiewicz (Warszawa)

Should patients with CRT be rehabilitated?
E. Smolis-Bąk (Warszawa)

Adult patient with a congenital disorder. The role of rehabilitation
A. Mawlichanów (Kraków)

Should patients with pulmonary arterial hypertension (PAH) be rehabilitated?
E. Piotrowicz (Warszawa)

Congestion in heart failure: overload or redistribution?

Congestion in heart failure: overload or redistribution?

Chairpersons: E. Straburzyńska-Migaj (Poznań)
Chairpersons: J. Drożdż (Łódź)

Pathophysiology and assessment of congestion
P. Rozentryt (Zabrze)

How to treat congestion and what to achieve in acute phase?
K. Mizia-Stec (Katowice)

How to prevent the recurrence of congestion?
J. Nessler (Kraków)

The heart in hypertension

The heart in hypertension

Chairpersons: Z. Gąsior (Katowice)
Chairpersons: A. Januszewicz (Warszawa)

Evaluation of left ventricular hypertrophy on ECG – new indices, are they better?
R. Baranowski (Warszawa)

Echocardiographic evaluation in hypertensive patient – in every patient?
A. Klisiewicz (Warszawa)

Effect of antihypertensive treatment on the regression of left ventricular hypertrophy – are there differences between drugs?
D. Czarnecka (Kraków)

The heart in primary and secondary hypertension – are there differences?
P. Dobrowolski (Warszawa)

Three dimensions of contemporary cardiology of cardiac defects

Three dimensions of contemporary cardiology of cardiac defects

Chairpersons: P. Hoffman (Warszawa)
Chairpersons: G. Brzezińska-Rajszys (Warszawa)

Difficult anatomy and even more difficult surgical decisions. Two dimensions supported by imagination or spatial imaging?
B. Maruszewski (Warszawa)

Three dimensional echocardiography. Attractive gadget or present-day instrument?
J. Kasprzak (Łódź)

Rotation, fusion, navigation – new words in interventionist's vocabulary
T. Moszura (Łódź), G. Brzezińska-Rajszys (Warszawa)

Planning with the heart in the hand – how 3D model supports the treatment of congenital cardiac malformations
A. Koleśnik (Warszawa)

„Tomorrow is today, but tomorrow” – progress in electrotherapy

„Tomorrow is today, but tomorrow” – progress in electrotherapy

Chairpersons: M. Kurpesa (Łódź)
Chairpersons: Z. Kalarus (Zabrze)

Subcutaneous implantable cardioverter-defibrillator. Current position in prevention of sudden cardiac death. First Polish experiences
P. Ptaszyński (Łódź)

Vagal nerve stimulator. An autonomic modulation in heart failure treatment
D. Jagielski (Wrocław)

Cardiac contractility modulation. A new option for heart failure patients
K. Kaczmarek (Łódź)

Leadless cardiac pacemaker. Further miniaturization of implantable cardiac devices – totally intracardiac stimulator
P. Mitkowski (Poznań)

Lifevest – sudden cardiac death protection as a bridging to implantable cardioverter-defibrillator
J. Wranicz (Łódź)

Revascularization in patients with non-ST elevation acute coronary syndromes (NSTE-ACS)

Revascularization in patients with non-ST elevation acute coronary syndromes (NSTE-ACS)

Chairpersons: R. Gil (Warszawa)
Chairpersons: M. Gąsior (Zabrze)

Risk assessment and decision making: revascularization or conservative treatment
T. Pawłowski (Warszawa)

Platelet inhibition and anticoagulation
S. Grajek (Poznań)

Percutaneous coronary intervention: indications and results
A. Witkowski (Warszawa)

Who is a candidate for surgical revascularization in the settings of NSTE-ACS?
M. Deja (Katowice)

Long-term management in NSTE-ACS patients after revascularization
W. Banasiak (Wrocław)

Today's look at the diagnosis and treatment of aortic stenosis – new hope for patients at high risk

Today's look at the diagnosis and treatment of aortic stenosis – new hope for patients at high risk

Session recommended by the Scientific Committee for PCS Congresses

Chairpersons: M. Zembala (Zabrze)
Chairpersons: A. Witkowski (Warszawa)

Diagnosis and qualification for the surgery of patients with aortic stenosis based on the latest AHA/ACC/ESC guidelines – is everything clear?
O. Trojnarska (Poznań)

Methods and results of conventional cardiac surgery in symptomatic aortic stenosis – whether cardiac surgery has said its last word?
K. Widenka (Rzeszów)

Transcatheter aortic valve implantation (TAVI) – highs and lows in 2016
M. Grygier (Poznań)

New types of TAVI systems – hope for better results
D. Dudek (Kraków)

Patient with suspected or diagnosed coronary disease. What imaging technique to use – anatomic, functional or both?

Patient with suspected or diagnosed coronary disease. What imaging technique to use – anatomic, functional or both?

Chairpersons: M. Demkow (Warszawa)
Chairpersons: M. Dziuk (Warszawa)

I definitely choose functional methods
M. Kostkiewicz (Kraków)

Coronary artery computed tomography as the first-choice imaging diagnostics in patients with high probability of coronary artery disease – preliminary results of CAT-CAD study
P. Rudziński (Warszawa)

My choice – anatomical methods
C. Kępka (Warszawa)

Hybrid imaging – it is the real future
M. Kruk (Warszawa)

Extreme effort and air pollution – do Poles know how to prevent a myocardial infarction?

Extreme effort and air pollution – do Poles know how to prevent a myocardial infarction?

Chairpersons: R. Topór-Mądry (Kraków)
Chairpersons: T. Zdrojewski (Gdańsk, Warszawa)
Chairpersons: R. Piotrowicz (Warszawa)

Cardiovascular health knowledge of adult Polish and its determinants.The results of two National Multicenter Health Surveys WOBASZ and WOBASZ II
A. Piwońska (Warszawa), W. Piotrowski (Warszawa), J. Piwoński (Warszawa), W. Drygas (Warszawa), W. Bielecki (Łódź), K. Kozakiewicz (Katowice), A. Pająk (Kraków), A. Tykarski (Poznań), T. Zdrojewski (Gdańsk, Warszawa)

Temporal trends in early and long-term (up to 5 years) mortality in all patients hospitalized in years 2009–2013 due to acute myocardial infarction in Poland – from nationwide population AMI-PL study
M. Gierlotka (Zabrze), T. Zdrojewski (Gdańsk, Warszawa), B. Wojtyniak (Warszawa), L. Poloński (Zabrze), M. Gąsior (Zabrze), K. Chlebus (Gdańsk), A. Kozierkiewicz (Warszawa), Ł. Wierucki (Gdańsk), J. Stokwiszewski (Warszawa), D. Rutkowski (Warszawa), Z. Kalarus (Zabrze), M. Wysocki (Warszawa), M. Zembala (Zabrze), P. Hoffman (Warszawa), G. Opolski (Warszawa)

Physical exercise in extreme heights and cardiovascular system. Is the cardiological screening important?
M. Kurdziel (Zabrze), K. Gierlaszyńska (Zabrze), A. Kazik (Zabrze), J. Wacławski (Zabrze), G. Pytel (Zabrze), A. Kurek (Zabrze), J. Wasilewski (Zabrze), L. Poloński (Zabrze), M. Gąsior (Zabrze)

Transient and rapid increase in the levels of cardiovascular stress biomarkers in amateur middle-aged male after marathon run
M. Kosowski (Wrocław), K. Młynarska (Wrocław), J. Chmura (Wrocław), E. Jankowska (Wrocław), W. Banasiak (Wrocław), J. Todd (Alameda), P. Ponikowski (Wrocław)

Summary – future prospects in epidemiology of cardiovascular diseases in Poland
T. Zdrojewski (Gdańsk, Warszawa), R. Topór-Mądry (Kraków)

Implantable device – from diagnostics to an optimal therapy

Implantable device – from diagnostics to an optimal therapy

Chairpersons: M. Sterliński (Warszawa)
Chairpersons: M. Kempa (Gdańsk)

The impact of remote monitoring of patients with implanted cardioverter-defibrillator (ICD) and cardiac resynchronization therapy device (CRT-D) on healthcare costs in long-term follow-up
P. Buchta (Zabrze), M. Tajstra (Zabrze), A. Kurek (Zabrze), M. Skrzypek (Katowice), M. Świetlińska (Zabrze), E. Gadula-Gacek (Zabrze), M. Wasiak (Zabrze), Ł. Pyka (Zabrze), M. Gąsior (Zabrze)

The incidence of silent atrial fibrillation in patients with pacemaker
M. Witkowski (Łódź), A. Bissinger (Łódź), A. Lubiński (Łódź)

Could one-year effect of cardiac resynchronization therapy on hemodynamic parameters evaluated by impedance cardiography be predicted
M. Orszulak (Katowice), A. Filipecki (Katowice), K. Mizia-Stec (Katowice)

The incidence and clinical significance of de novo depression after shock delivery in cardiac resynchronization therapy recipients
T. Podolecki (Zabrze), R. Pudlo (Zabrze), R. Lenarczyk (Zabrze), M. Mazurek (Zabrze), E. Jędrzejczyk-Patej (Zabrze), M. Kozieł (Zabrze), J. Boidol (Zabrze), A. Liberska (Zabrze), J. Kowalczyk (Zabrze), O. Kowalski (Zabrze), Z. Kalarus (Zabrze)

Summary – home-monitoring in 2016
M. Grabowski (Warszawa)

Case study

Case study

Chairpersons: B. Jankowska-Polańska (Wrocław)
Chairpersons: I. Uchmanowicz (Wrocław)

Arteriovenous ECMO as a method supporting acute cardiopulmonary failure after coronary Artery Bypass Graft (CABG) – case study
Ł. Czyżewski (Warszawa), Ł. Szarpak (Warszawa), A. Kurowski (Warszawa)

Tasks and competences of a nurse in care for a pediatric patient with high risk of sudden cardiac death (SCD) based on the case study of a patient with Brugada syndrome
R. Mroczkowska (Katowice), G. Ptaszek (Katowice), B. Stolecka (Katowice), P. Gurowiec (Zabrze)

Different clinical course of reflex syncope in women
I. Bzukała (Kraków), J. Jędrzejczyk-Spaho (Kraków), A. Borowiec (Kraków), M. Frączek (Kraków), P. Wiśniewski (Kraków), M. Kalinowska (Kraków), A. Pietrucha (Kraków), R. Konior (Kraków), J. Nessler (Kraków)

Studies which have influenced contemporary cardiology. Dreams… and what next?

Studies which have influenced contemporary cardiology. Dreams… and what next?

Chairpersons: E. Płońska-Gościniak (Szczecin)
Chairpersons: Z. Kornacewicz-Jach (Szczecin)
Chairpersons: J. Kaźmierczak (Szczecin)

Facts and myths about preventive cardiology
Z. Kornacewicz-Jach (Szczecin)

Invasive evaluation of coronary flow reserve (CFR): standards and the cardiology market
J. Gorący (Szczecin)

The future of minimally invasive imaging examinations – the necessity of different than ultrasound methods in everyday clinical practice
E. Płońska-Gościniak (Szczecin)

Invasive treatment of atrial fibrillation: the cost/the effect in long-term observation
J. Kaźmierczak (Szczecin)

Echocardiography in qualification for electrotherapy and the diagnosis of its complications
A. Wojtarowicz (Szczecin)

The female heart
M. Peregud-Pogorzelska (Szczecin)

Ablation

Ablation

Moderator: Ł. Szumowski (Warszawa)
Moderator: K. Błaszyk (Poznań)

Efficacy and safety of zero-fluoroscopy ablation for idiopathic ventricular arrhythmias
B. Ludwik (Wrocław), J. Śledź (Ostrowiec Świętokrzyski), M. Mazij (Trzebnica), D. Karbarz (Radom), K. Deutsch (Kielce), L. Szydłowski (Katowice), M. Klank-Szafran (Kielce), M. Chrabąszcz (Kielce), M. Labus (Wrocław), T. Kameczura (Sanok), J. Śpikowski (Wrocław), A. Morka (Kraków), S. Stec (Warszawa)

The impact of Ensite utilization in pediatric arrhythmia ablation on safety, procedure duration and number of RF lesions. Is it time to change the approach?
A. Baszko (Poznań), K. Czyż (Poznań), A. Łaźniak (Poznań), W. Bobkowski (Poznań), A. Siwińska (Poznań)

Atrial fibrillation burden after cryoballoon ablation using subcutaneous injectable loop recorder (LINQ) assessment
M. Jastrzębski (Kraków), A. Kusiak (Kraków), A. Bednarski (Kraków), E. Koźluk (Warszawa), A. Baszko (Poznań), A. Piątkowska (Warszawa), R. Piotrowski (Warszawa, Rzeszów), P. Kułakowski (Warszawa, Rzeszów), D. Czarnecka (Kraków)

Fluoroscopy integrated with 3D mapping system. A new method of further reduction of fluoroscopy during ablation of atrial fibrillation
K. Myrda (Zabrze), P. Buchta (Zabrze), M. Witek (Zabrze), M. Gąsior (Zabrze)

Global atrial longitudinal strain is a powerful predictor of catheter ablation efficacy in patients with atrial fibrillation
E. Pilichowska-Paszkiet (Warszawa), J. Baran (Warszawa), P. Kułakowski (Warszawa, Rzeszów), B. Zaborska (Warszawa)

Silent cerebral embolism after left-sided accessory pathway ablation in Wolff-Parkinson-White syndrome
A. Głowniak (Lublin), A. Tarkowski (Lublin), A. Jaroszyńska (Lublin), M. Janczarek (Lublin), A. Wysocka (Lublin), D. Stettner-Leonkiewicz (Lublin), M. Szczerbo-Trojanowska (Lublin), A. Wysokiński (Lublin)

The safety and feasibility of conscious sedation during cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation
D. Miśkowiec (Łódź), J. Kasprzak (Łódź), P. Życiński (Łódź), H. Qawoq (Łódź), T. Wcisło (Łódź), K. Kupczyńska (Łódź), P. Lipiec (Łódź)

Non-fluoroscopic catheter ablation of ventricular arrhythmias – a single center experience
P. Futyma (Rzeszów), K. Ciąpała (Rzeszów), R. Piotrowski (Warszawa, Rzeszów), K. Dudek (Rzeszów), J. Sander (Rzeszów), M. Maciołek (Rzeszów), M. Futyma (Rzeszów), P. Kułakowski (Warszawa, Rzeszów)

Invasive cardiology

Invasive cardiology

Moderator: K. Milewski (Katowice)
Moderator: P. Pieniążek (Kraków)

Does the effectiveness of recanalization of chronic occlusion depend on the location of obstruction?
L. Bryniarski (Kraków), Ł. Klima (Kraków), M. Terlecki (Kraków), P. Jankowski (Kraków), M. Rajzer (Kraków), K. Bryniarski (Kraków), T. Królikowski (Kraków), A. Curyło (Kraków), K. Żmudka (Kraków), D. Dudek (Kraków), D. Czarnecka (Kraków), S. Surowiec (Kraków)

Balloon valvuloplasty – still vital tool in TAVI era
J. Wacławski (Zabrze), K. Wilczek (Zabrze), D. Pres (Zabrze), M. Hawranek (Zabrze), M. Zembala (Zabrze), M. Zembala (Zabrze), M. Gąsior (Zabrze)

Impact of coronary artery disease burden on 12-month mortality of patients after transcatheter aortic valve implantation
P. Kleczyński (Kraków), M. Bagieński (Kraków), A. Dziewierz (Kraków), Ł. Rzeszutko (Kraków), D. Sorysz (Kraków), J. Trębacz (Kraków), R. Sobczyński (Kraków), M. Tomala (Kraków), A. Gackowski (Kraków), D. Dudek (Kraków)

Comparison of predictors, early and long-term outcomes of transradial versus transfemoral access site used for coronary angiography in real-life population – insights from Prospective Registry of Stable Angina management and treatment (PRESAGE registry)
M. Hawranek (Zabrze), P. Trzeciak (Zabrze), P. Desperak (Katowice), A. Ciślak (Katowice, Zabrze), D. Duda-Pyszny (Zabrze), M. Skrzypek (Katowice), D. Cieśla (Zabrze), A. Lekston (Zabrze), L. Poloński (Zabrze), M. Gąsior (Zabrze)

Clinical outcome, long-term survival and prognostic factors of cardiovascular events in patients treated with percutaneous angioplasty for renal artery stenosis
A. Rosławiecka (Kraków), T. Przewłocki (Kraków), K. Żmudka (Kraków), P. Pieniążek (Kraków), R. Badacz (Kraków), A. Kabłak-Ziembicka (Kraków), D. Rzeźnik (Kraków)

Impact of pre-procedural coronary artery disease assessed by SYNTAX score on transcatheter aortic valve implantation outcome
Z. Huczek (Warszawa), K. Zbroński (Zabrze, Warszawa), K. Grodecki (Warszawa), J. Kochman (Warszawa), P. Ścisło (Warszawa), M. Dąbrowski (Warszawa), A. Witkowski (Warszawa), Z. Chmielak (Warszawa), M. Grygier (Poznań), A. Olasińska-Wiśniewska (Poznań), A. Araszkiewicz (Poznań), M. Lesiak (Poznań), R. Wilimski (Warszawa), D. Puchta (Warszawa), K. Paczwa (Warszawa), K. Filipiak (Warszawa), G. Opolski (Warszawa)

Outcomes and clinical predictors of mortality of patients treated with rotational atherectomy: a single center registry
P. Kubler (Wrocław), W. Zimoch (Wrocław), M. Kosowski (Wrocław), B. Tomasiewicz (Wrocław), A. Telichowski (Wrocław), K. Reczuch (Wrocław)

Transcatheter paravalvular leak closure and hemolysis – prospective registry
G. Smolka (Katowice), P. Pysz (Katowice), M. Kozłowski (Katowice), W. Wańha (Katowice), A. Ochała (Katowice), W. Wojakowski (Katowice)

Hybrid or staged carotid artery stenting and cardiac surgery as the treatment strategy for patients with severe, concurrent carotid and cardiac disease
K. Dzierwa (Kraków), J. Piątek (Kraków), J. Konstanty-Kalandyk (Kraków), P. Paluszek (Kraków), Ł. Tekieli (Kraków), M. Trystuła (Kraków), M. Michalski (Kraków), R. Drwiła (Kraków), P. Pieniążek (Kraków), K. Żmudka (Kraków)

Acute and chronic pulmonary circulatory disorders

Acute and chronic pulmonary circulatory disorders

Moderator: M. Ciurzyński (Warszawa)
Moderator: G. Kopeć (Kraków)

Atrial fibrillation in patients with acute pulmonary embolism: an enemy or a bystander
A. Krajewska (Białystok), I. Kiluk (Białystok), R. Milewski (Białystok), U. Kosacka (Białystok), B. Sobkowicz (Białystok)

Age-adjusted D-Dimer cut-off values in suspected acute pulmonary embolism to avoid unnecessary contrast enhanced examinations
M. Kozłowska (Warszawa), M. Pływaczewska (Warszawa), M. Ciurzyński (Warszawa), M. Koć (Warszawa), M. Paczyńska (Warszawa), K. Kurnicka (Warszawa), M. Kostrubiec (Warszawa), A. Wyzgał (Warszawa), S. Pacho (Warszawa), M. Wiśniewska (Warszawa), P. Pruszczyk (Warszawa)

Early changes in arterial blood saturation as a marker of balloon pulmonary angioplasty effectiveness
W. Magoń (Kraków), J. Stępniewski (Kraków), M. Waligóra (Kraków), K. Jonas (Kraków), P. Podolec (Kraków), G. Kopeć (Kraków)

Reduction of major bleeding complication in patients hospitalized due to acute pulmonary embolism in reference cardiology center after implementation of the 2008 ESC guidelines into clinical practice
I. Skoczylas (Zabrze), W. Skowron (Zabrze), M. Gierlotka (Zabrze), A. Nowowiejska-Wiewióra (Zabrze), A. Majsnerowska (Zabrze), K. Dyrbuś (Zabrze), K. Gierlaszyńska (Zabrze), A. Gutowski (Zabrze), R. Przybylski (Zabrze), M. Zembala (Zabrze), M. Gąsior (Zabrze), L. Poloński (Zabrze)

High-density lipoprotein cholesterol level as a predictor of vasoreactivity in patients with idiopathic pulmonary arterial hypertension
K. Jonas (Kraków), M. Waligóra (Kraków), P. Podolec (Kraków), G. Kopeć (Kraków)

Increased systemic arterial stiffness in patients with chronic thromboembolic pulmonary hypertension
M. Sznajder (Warszawa), O. Dzikowska-Diduch (Warszawa), K. Kurnicka (Warszawa), P. Pruszczyk (Warszawa), M. Kostrubiec (Warszawa)

Long-term outcomes for patients with pulmonary arterial hypertension treated with specific drug therapy in 2007–2016
I. Skoczylas (Zabrze), A. Majsnerowska (Zabrze), A. Nowowiejska-Wiewióra (Zabrze), K. Gierlaszyńska (Zabrze), M. Gierlotka (Zabrze), J. Szkodziński (Zabrze), K. Dyrbuś (Zabrze), P. Walczak (Katowice), M. Kurcz (Zabrze, Katowice), A. Lekston (Zabrze), M. Zembala (Zabrze), M. Gąsior (Zabrze), L. Poloński (Zabrze)

P-selectin and sTWEAK content in platelets is diminished in patients with pulmonary arterial hypertension
R. Kazimierczyk (Białystok), M. Jasiewicz (Białystok), K. Kowal (Białystok), E. Waszkiewicz (Białystok), B. Sobkowicz (Białystok), W. Musiał (Białystok), K. Kamiński (Białystok)

Preoperative echocardiography examination of right ventricle function in patients scheduled for LVAD implantation correlates with postoperative hemodynamic examinations
P. Nadziakiewicz (Zabrze), T. Niklewski (Zabrze), B. Szyguła-Jurkiewicz (Zabrze), J. Pacholewicz (Zabrze), J. Borkowski (Zabrze), T. Hrapkowicz (Zabrze), M. Zembala (Zabrze)

Complications of electrotherapy

Complications of electrotherapy

Moderator: A. Przybylski (Rzeszów)
Moderator: A. Maciąg (Warszawa)

Radiotherapy can cause serious malfunction of modern implantable cardioverters-defibrillators (ICD) and cardiac resynchronization therapy defibrillator (CRT-D)
M. Tajstra (Zabrze), S. Blamek (Gliwice), E. Gadula-Gacek (Zabrze), M. Gąsior (Zabrze)

Risk factors of late infectious complications in patients with cardiac implantable electronic devices
A. Polewczyk (Kielce), W. Jacheć (Zabrze), M. Janion (Kielce), A. Kutarski (Lublin)

Early and long-term complications in more than one thousand recipients of implantable cardioverter-defibrillator or cardiac resynchronization therapy defibrillators – insights from the Silesian Center Defibrillator Registry
M. Tajstra (Zabrze), E. Gadula-Gacek (Zabrze), A. Kurek (Zabrze), D. Olszowski (Zabrze), M. Ostręga (Zabrze), E. Adamowicz-Czoch (Zabrze), Ł. Pyka (Zabrze), A. Ciślak (Katowice, Zabrze), L. Poloński (Zabrze), A. Lekston (Zabrze), M. Gąsior (Zabrze)

Infectious complications in patients with cardiac resynchronisation therapy – risk factors and long-term prognosis
A. Polewczyk (Kielce), W. Jacheć (Zabrze), G. Opolski (Warszawa), M. Grabowski (Warszawa), M. Janion (Kielce), A. Kutarski (Lublin)

Can anticoagulation play preventive role in lead related venous occlusion? Findings of 1573 preoperative venographies
M. Czajkowski (Lublin), W. Dąbrowski (Lublin), W. Jacheć (Zabrze), A. Tomasik (Zabrze), A. Kutarski (Lublin)

Risks related to extraction of lead having long dwell time. Experience obtained from 2036 transvenous lead extraction procedures
A. Kutarski (Lublin), M. Czajkowski (Lublin), A. Tomasik (Zabrze), A. Polewczyk (Kielce), W. Jacheć (Zabrze)

Venous occlusion and stenosis in CIED carriers; chance of safe and effective utility of ipsilateral jugular venous approach for intensive therapy, anaesthesia and catheter haemodialysis. Analysis of 1633 venograms
M. Czajkowski (Lublin), W. Dąbrowski (Lublin), W. Jacheć (Zabrze), A. Tomasik (Zabrze), A. Kutarski (Lublin)

Transvenous lead extraction in children and young patients. Differences compared with adult patients
A. Kutarski (Lublin), W. Jacheć (Zabrze), A. Tomasik (Zabrze), M. Czajkowski (Lublin), M. Polewczyk (Kielce), A. Polewczyk (Kielce), A. Polewczyk (Kielce), M. Miszczak-Knecht (Warszawa), K. Bieganowska (Warszawa)

The usefulness of CRP and white blood cell count in indentifying infectious complications of permament cardiac pacing
A. Ząbek (Kraków), K. Boczar (Kraków), M. Dębski (Kraków), K. Haberka (Kraków), R. Musiał (Kraków), A. Rydlewska (Kraków), J. Lelakowski (Kraków), B. Małecka (Kraków)

Factors infuencing early and long-term prognosis after transvenous lead extraction procedures in patients with lead-dependent infective endocarditis
A. Polewczyk (Kielce), W. Jacheć (Zabrze), A. Tomaszewski (Lublin), W. Brzozowski (Lublin), M. Czajkowski (Lublin), G. Opolski (Warszawa), M. Grabowski (Warszawa), M. Janion (Kielce), A. Kutarski (Lublin)

The role of cardiac surgery in patients undergoing transvenous lead extraction. Experience from 2073 procedures in the high volume center
A. Kutarski (Lublin), M. Czajkowski (Lublin), S. Targońska (Lublin), Ł. Tułecki (Zamość), K. Tomków (Zamość), A. Tomasik (Zabrze), A. Polewczyk (Kielce), W. Jacheć (Zabrze), J. Stążka (Lublin)

Risk factors of major transvenous lead extraction complications; the role of abandoned lead extraction. Experience from 1915 procedures
A. Kutarski (Lublin), M. Polewczyk (Kielce), W. Jacheć (Zabrze), A. Polewczyk (Kielce), A. Tomasik (Zabrze), M. Czajkowski (Lublin), A. Polewczyk (Kielce)

Prevention of cardiovascular diseases: advanced diagnostic techniques

Prevention of cardiovascular diseases: advanced diagnostic techniques

Moderator: B. Cybulska (Warszawa)
Moderator: P. Jankowski (Kraków)
Moderator: A. Pająk (Kraków)

CHA2DS2-Vasc score, as well as age and body mass index as the main risk factors of brain lesions in asymptomatic patients with paroxysmal non-valvular atrial fibrillation
J. Wieczorek (Katowice), K. Mizia-Stec (Katowice), P. Wieczorek (Katowice), A. Lasek-Bal (Katowice), A. Hoffmann (Katowice), S. Nowak (Katowice), J. Kolasa (Katowice), M. Faryan (Katowice), I. Woźniak-Skowerska (Katowice), A. Wnuk-Wojnar (Katowice)

No impact of omega-3 PUFAs on platelet aggregation, thrombin generation and fibrin clot properties in patients with atherosclerosis and type 2 diabetes mellitus on optimal pharmacological therapy
M. Mostowik (Kraków), A. Siniarski (Kraków), M. Poręba (Kraków), R. Gołębiowska-Wiatrak (Kraków), J. Nessler (Kraków), G. Gajos (Kraków)

Efficacy and safety of lipoprotein apheresis by double cascade filtration and direct hemadsorption in severe heterozygous familial hypercholesterolemia
A. Mickiewicz (Gdańsk), W. Bachorski (Gdańsk), J. Borowiec (Gdańsk), M. Chmara (Gdańsk), B. Wasąg (Gdańsk), A. Rynkiewicz (Gdańsk), G. Raczak (Gdańsk), M. Fijałkowski (Gdańsk), M. Gruchała (Gdańsk)

Matrix Metalloproteinases 2 and 9, Tissue Inhibitors of Metalloproteinases 1 and 2 in plasma of patients with lower limb chronic ischemia and coexisting stable angina
R. Wieczór (Bydgoszcz), A. Wieczór (Bydgoszcz), B. Góralczyk (Bydgoszcz), J. Fabisiak (Bydgoszcz), G. Pulkowski (Bydgoszcz), J. Budzyński (Bydgoszcz), D. Rość (Bydgoszcz)

Insulin-like growth factor-binding protein 7 (IGFBP 7) as a new biomarker in coronary heart disease
A. Lisowska (Białystok), M. Knapp (Białystok), W. Musiał (Białystok), P. Świecki (Białystok), M. Gil (Białystok), K. Kamiński (Białystok), T. Hirnle (Białystok), A. Tycińska (Białystok)

The correlation of HDL with biomarkers of inflammation in patients with early stages of coronary atherosclerosis
E. Kaczmarska (Warszawa), Z. Dzielińska (Warszawa), C. Kępka (Warszawa), Z. Bilińska (Warszawa), K. Kryczka (Warszawa), R. Pracoń (Warszawa), M. Kruk (Warszawa), J. Pręgowski (Warszawa), M. Demkow (Warszawa)

11:00 - 12:30

Controversies in electrocardiology

Controversies in electrocardiology

Chairpersons: J. Kaźmierczak (Szczecin)
Chairpersons: K. Bieganowska (Warszawa)

I always precede implantation of ICD with VT-substrate ablation
Pro: Ł. Szumowski (Warszawa)
Contra: A. Lubiński (Łódź)

I perform cardiac ablation in each patient with asymptomatic features of ventricular pre-excitation pattern on ECG
Pro: O. Kowalski (Zabrze)
Contra: R. Baranowski (Warszawa)

Imaging in hypertension and coexisting diseases

Imaging in hypertension and coexisting diseases

Session recommended by Scientific Committee for PCS Congresses

Chairpersons: P. Hoffman (Warszawa)
Chairpersons: A. Januszewicz (Warszawa)
Chairpersons: P. Pruszczyk (Warszawa)

Heart (MRI, CT)
T. Miszalski-Jamka (Kraków, Wrocław)

Heart (echocardiography)
A. Klisiewicz (Warszawa)

Large vessels
P. Krzesiński (Warszawa)

Carotid and renal arteries
A. Kabłak-Ziembicka (Kraków)

Early primary prevention of cardiovascular diseases

Early primary prevention of cardiovascular diseases

Chairpersons: A. Fijałkowska (Warszawa)
Chairpersons: W. Drygas (Warszawa)

Prevention of cardiovascular diseases and genetic conditions
M. Ambroziak (Warszawa)

Prevention of obesity in children – role of nutrition
B. Skowrońska (Poznań), A. Krasińska (Poznań)

The role of physical activity in children and youth
A. Fijałkowska (Warszawa)

Prevention strategies from prenatal phase to adulthood
A. Pająk (Kraków)

When ECG can be misinterpreted – or how not to cut corners analyzing electrocardiogram

When ECG can be misinterpreted – or how not to cut corners analyzing electrocardiogram

Chairpersons: M. Kurpesa (Łódź)
Chairpersons: L. Bryniarski (Kraków)

When I was surprised by ECG but not by a patient – what the heart can see?
P. Kukla (Gorlice)

Abnormal ECG before and after interventions – what the heart remembers and what it reminds of?
S. Stec (Warszawa)

Seemingly normal and seemingly abnormal ECG in a patient with a pacemaker
M. Jastrzębski (Kraków)

When an invasive cardiologist finds ECG confusing – does angiogram shows something different than ECG?
L. Bryniarski (Kraków)

Advances and controversies in the treatment of stable coronary artery disease

Advances and controversies in the treatment of stable coronary artery disease

Chairpersons: M. Zembala (Zabrze)
Chairpersons: D. Dudek (Kraków)

The primary treatment of stable coronary artery disease is optimal medical therapy
Pro: W. Banasiak (Wrocław)
Contra: A. Ochała (Katowice)

The primary method of revascularization of patients with stable coronary artery disease and stenosis and/or multivessel disease is coronary artery bypass grafting
Pro: M. Krejca (Katowice)
Contra: J. Legutko (Kraków)

Optimal management and innovative approaches for mechanical complications in acute myocardial infarction

Optimal management and innovative approaches for mechanical complications in acute myocardial infarction

Chairpersons: J. Różański (Warszawa)
Chairpersons: W. Wojakowski (Katowice)

Free wall rupture – immediate diagnosis is the key
M. Hawranek (Zabrze)

Acute mitral regurgitation – the possibilities of interventional cardiologist
R. Gil (Warszawa)

Acute mitral regurgitation – the domain of a cardiac surgeon
K. Widenka (Rzeszów)

Ventricular septal rupture – do we have an idea how to treat it effectively?
J. Zalewski (Kraków)

The newest guidelines of ESC/PCS 2016

The newest guidelines of ESC/PCS 2016

Session of the PCS Committee on Guidelines and Education

Chairpersons: M. Tendera (Katowice)
Chairpersons: A. Torbicki (Otwock)

Management of acute and chronic heart failure
E. Jankowska (Wrocław)

Cardiovascular disease prevention in clinical practice
P. Jankowski (Kraków)

Management of dyslipidemias
A. Rynkiewicz (Gdańsk)

Management of atrial fibrillation
P. Ponikowski (Wrocław)

Infective endocarditis – what is new?

Infective endocarditis – what is new?

Session recommended by the Scientific Committee for PCS Congresses

Chairpersons: T. Hirnle (Białystok)
Chairpersons: E. Płońska-Gościniak (Szczecin)

The application of the ECHO test – what is new?
P. Lipiec (Łódź)

CT – in whom? when could it be helpful?
I. Michałowska (Warszawa)

SPECT and PET – in whom? when could it be helpful?
M. Kostkiewicz (Kraków)

Who and when should be operated?
J. Stępińska (Warszawa)

Cardiac device-related infective endocarditis – what is new?
P. Mitkowski (Poznań)

Modern treatment of difficult patients in ICCU based on clinical cases

Modern treatment of difficult patients in ICCU based on clinical cases

Chairpersons: B. Średniawa (Zabrze)
Chairpersons: A. Budaj (Warszawa)
Discussion panel: M. Gierlotka (Zabrze)
Discussion panel: A. Tycińska (Białystok)
Discussion panel: Ł. Krzych (Zabrze)
Discussion panel: M. Deja (Katowice)

Patient with advanced HF and RRT
P. Siwołowski (Wrocław)

Patient with electrical storm and ECMO
M. Tajstra (Zabrze)

Unconscious patient with STEMI and MTH
A. Świątkowski (Zabrze)

Patient with AF treated with NOAC requiring cardioversion and TEE
P. Góral (Warszawa)

ACS – the new experience

ACS – the new experience

Chairpersons: Z. Chmielak (Warszawa)
Chairpersons: M. Grygier (Poznań)

The prognosis and invasive treatment of patients with NSTEMI depend on the electrocardiographic changes on admission to hospital – data from PL-ACS registry
M. Owsiak (Kraków), L. Poloński (Zabrze), M. Gierlotka (Zabrze), E. Mirek-Bryniarska (Kraków), M. Gąsior (Zabrze), K. Bryniarski (Kraków), L. Bryniarski (Kraków)

Benefits in bleeding rates and periprocedural mortality of radial approach in ST-segment elevation myocardial infarction. Propensity score analysis of data from ORPKI Polish National Registry
T. Tokarek (Kraków), T. Wysocki (Pińczów), Z. Siudak (Kraków), A. Sawina (Kraków), J. Legutko (Kraków), K. Żmudka (Kraków), D. Dudek (Kraków)

Early and 1-year clinical outcomes of patients with heavily calcified coronary artery lesions presenting with acute coronary syndromes treated with rotational atherectomy
M. Kosowski (Wrocław), W. Zimoch (Wrocław), P. Kubler (Wrocław), B. Tomasiewicz (Wrocław), A. Telichowski (Wrocław), K. Reczuch (Wrocław)

Multivessel percutaneous coronary intervention versus coronary artery bypass grafting for patients with non-ST-segment elevation acute coronary syndromes in routine clinical practice
M. Hawranek (Zabrze), P. Desperak (Katowice), A. Ciślak (Katowice, Zabrze), D. Cieśla (Zabrze), D. Pres (Zabrze), Ł. Pyka (Zabrze), M. Gierlotka (Zabrze), A. Lekston (Zabrze), L. Poloński (Zabrze), M. Gąsior (Zabrze)

Transcatheter closure of postinfarction ventricular septal defect – in-hospital outcome and follow-up analysis
M. Gałeczka (Zabrze), R. Fiszer (Zabrze), J. Białkowski (Zabrze), M. Szkutnik (Zabrze), D. Szulik (Zabrze), M. Knop (Zabrze), B. Zeifert (Zabrze), B. Chodór (Zabrze), M. Żyła-Frycz (Zabrze)

Summary – progress and controversies in interventional treatment of acute coronary syndromes
A. Dziewierz (Kraków)

Electrophysiology and electrotherapy – untypical problems of typical patients

Electrophysiology and electrotherapy – untypical problems of typical patients

Chairpersons: K. Kaczmarek (Łódź)
Chairpersons: M. Grabowski (Warszawa)

Bipolar irrigated radiofrequency ablation of resistant ventricular tachycardia with a septal intramural origin:
A. Baszko (Poznań), P. Kałmucki (Poznań), P. Iwachów (Poznań), K. Kochman (Poznań)

Should we implant a permanent pacemaker in patients with left bundle brunch block and PQ prolongation following transcatheter aortic valve implantation?
K. Błaszyk (Poznań), A. Komosa (Poznań), M. Grygier (Poznań), A. Araszkiewicz (Poznań), M. Lesiak (Poznań), A. Olasińska-Wiśniewska (Poznań), S. Grajek (Poznań)

Hybrid ablation supported by left ventricular assist device in patient with hemodynamic unstable ventricular tachycardia storm
P. Buchta (Zabrze), M. Hawranek (Zabrze), M. Zembala (Zabrze), K. Filipiak (Zabrze), K. Myrda (Zabrze), R. Koba (Zabrze), M. Witek (Zabrze), M. Gąsior (Zabrze)

Asymptomatic pulmonary embolism after transvenous lead extraction due to lead-dependent infective endocarditis with large vegetations
A. Tomaszewski (Lublin), A. Wojtkowska (Lublin), A. Kutarski (Lublin), M. Tomaszewski (Lublin)

Challenges for a cardiologist in health care for a pregnant patient: cardiac tumor, cardiomyopathy, anticoagulation

Challenges for a cardiologist in health care for a pregnant patient: cardiac tumor, cardiomyopathy, anticoagulation

Chairpersons: K. Mizia-Stec (Katowice)
Chairpersons: P. Rubiś (Kraków)

Anticoagulation is a challenge not only for the cardiologists
A. Lisowska (Białystok), M. Giaro (Słupsk), P. Lisowski (Białystok), M. Knapp (Białystok), W. Musiał (Białystok)

Malignant tumor of the right atrium in a pregnant woman – first manifestation by paroxysmal atrial fibrillation
J. Kudlicki (Lublin), A. Kania (Lublin), A. Frania-Baryluk (Lublin), P. Aljabali (Lublin), A. Wysokiński (Lublin), P. Adamczyk (Lublin), E. Czekajska-Chehab (Lublin)

Advanced hypertrophic cardiomyopathy diagnosed in early pregnancy – prevention of sudden cardiac death
J. Kudlicki (Lublin), A. Frania-Baryluk (Lublin), A. Kania (Lublin), A. Wysokiński (Lublin)

Imaging of big vessels in patients with congenital heart defects – what to choose?

Imaging of big vessels in patients with congenital heart defects – what to choose?

Chairpersons: O. Trojnarska (Poznań)
Chairpersons: T. Mroczek (Kraków)
Chairpersons: J. Kusa (Wrocław)

I choose MRI, because...
M. Śpiewak (Warszawa)

Precision and safety of interventions are my priority, so...
G. Brzezińska-Rajszys (Warszawa), T. Moszura (Łódź)

I want to see, touch, simulate, since...
A. Koleśnik (Warszawa)

I do computed tomography due to...
T. Miszalski-Jamka (Kraków, Wrocław)

Diagnostics and treatment of congestive heart failure

Diagnostics and treatment of congestive heart failure

Moderator: J. Nessler (Kraków)
Moderator: J. Drożdż (Łódź)

Depression in Polish patients with heart failure – the prevalence and independent predictors. Results of a CAPS-LOCK-HF (Complex Assessment of Psychological Status Located in Heart Failure) study
M. Orszulak (Katowice), K. Mizia-Stec (Katowice), A. Siennicka (Wrocław), B. Michalski (Łódź), F. Szymański (Warszawa), K. Ptaszyńska-Kopczyńska (Białystok), M. Wojcik (Lublin), R. Błaszczyk (Lublin), G. Kopeć (Kraków), K. Gościńska-Bis (Katowice), K. Waga (Katowice), P. Nadrowski (Katowice), A. Szymańska (Warszawa), Ł. Krzych (Zabrze), E. Jankowska (Wrocław)

Assessment of thromboembolic risk and antithrombotic treatment in population of Polish patients with heart failure and atrial fibrillation in European Society of Cardiology Heart Failure Long-term Registry
M. Kluk (Kielce), R. Bartkowiak (Kielce), B. Sosnowska-Pasiarska (Kielce), B. Wożakowska-Kapłon (Kielce), G. Opolski (Warszawa), P. Ponikowski (Wrocław), L. Poloński (Zabrze), J. Drożdż (Łódź)

The journey of the heart failure patient based on single-centre data analysis
J. Berner (Łódź), A. Chuda (Łódź), P. Łęczycki (Łódź), M. Lelonek (Łódź)

The value of echocardiographic TEI index, E/E' ratio and BNP serum level in patients with heart failure with preserved ejection fraction
D. Karasek (Bydgoszcz), W. Gilewski (Bydgoszcz), J. Błażejewski (Bydgoszcz), R. Bujak (Bydgoszcz), J. Banach (Bydgoszcz), W. Sinkiewicz (Bydgoszcz)

Management of systolic heart failure in ambulatory care in Poland – data from the international QUALIFY survey
G. Opolski (Warszawa), K. Ozierański (Warszawa), M. Lelonek (Łódź), A. Wilkins (Warszawa), P. Ponikowski (Wrocław)

Quality of life in patients with heart failure and sleep apnea. Results of the Hart Failure Quality of Life (HEAL-QoL) study
T. Pawłowski (Katowice), T. Jadczyk (Katowice), K. Barański (Katowice), M. Syzdół (Katowice), M. Sitko (Katowice), P. Nadrowski (Katowice), M. Jędrzejek (Katowice), M. Tendera (Katowice), W. Wojakowski (Katowice)

Impact of concomitant type 2 diabetes mellitus and its treatment on long-term outcome in systolic heart failure patients
Ł. Pyka (Zabrze), A. Kurek (Zabrze), K. Strojek (Zabrze), Ł. Siedlecki (Zabrze), M. Hawranek (Zabrze), M. Tajstra (Zabrze), M. Gierlotka (Zabrze), A. Lekston (Zabrze), M. Zembala (Zabrze), M. Gąsior (Zabrze)

The influence of metabolic syndrome on 1-year surveillance of patients with chronic heart failure without atrial fibrillation
M. Wełnicki (Warszawa), D. Śliż (Warszawa), J. Szeligowska (Warszawa), D. Dąbrowska (Warszawa), P. Ponikowski (Wrocław), G. Opolski (Warszawa), P. Rozentryt (Zabrze), A. Kleinrok (Zamość), W. Sinkiewicz (Bydgoszcz), B. Wożakowska-Kapłon (Kielce), J. Drożdż (Łódź), A. Mamcarz (Warszawa)

How elderly patients with chronic heart failure are treated in clinical practice? – the subanalysis of DATA-HELP registry
J. Krzysztofik (Wrocław), W. Banasiak (Wrocław), B. Kurian (Warszawa), P. Ponikowski (Wrocław), E. Jankowska (Wrocław)

Fractional urinary excretion of potassium – mortality and treatment pattern in heart failure
P. Rozentryt (Zabrze), J. Niedziela (Zabrze), J. Nowak (Zabrze), B. Hudzik (Zabrze), P. Leszek (Warszawa), T. Rywik (Warszawa), M. Gąsior (Zabrze)

Calculated colloid osmotic pressure as an independent risk factor of mortality in patients with chronic heart failure
J. Niedziela (Zabrze), B. Hudzik (Zabrze), P. Rozentryt (Zabrze), N. Niedziela (Zabrze), J. Nowak (Zabrze), A. Ociessa (Zabrze), M. Gąsior (Zabrze)

Experimental cardiology

Experimental cardiology

Moderator: A. Beręsewicz (Warszawa)
Moderator: M. Kurpisz (Poznań)

The effects of dabigatran on prothrombin, factor VII and tissue factor expression in human aortic valve interstitial cells
E. Wypasek (Kraków), J. Natorska (Kraków), P. Kapusta (Kraków), P. Mazur (Kraków), A. Undas (Kraków)

Transcriptional activity of nuclear factor kappa B (NF-κB) in patients with early stages of coronary artery disease and cardiovascular risk factors – preliminary observations
J. Dąbek (Katowice), M. Bałys (Katowice), J. Głogowska-Ligus (Katowice), Z. Gąsior (Katowice)

The miRNA-21 levels are associated with serum lipids profile in early phase of non-ST elevation acute coronary syndromes
D. Miśkowiec (Łódź), P. Lipiec (Łódź), K. Kupczyńska (Łódź), B. Michalski (Łódź), M. Simiera (Łódź), K. Wierzbowska-Drabik (Łódź), J. Kasprzak (Łódź)

MicroRNA’s expression in cerebral ischemia resulting from carotid artery stenosis – the immediate findings and long-term prognosis
I. Karch (Kraków), A. Kabłak-Ziembicka (Kraków), R. Badacz (Kraków), E. Stępień (Kraków), F. Enguita (Lizbona), J. Gacoń (Tarnów), K. Żmudka (Kraków), T. Przewłocki (Kraków)

Antazoline – effective antiarrhythmic drug for acute termination of atrial fibrillation. Insights into drug-induced electrocardiographic and haemodynamic effects
R. Piotrowski (Warszawa, Rzeszów), J. Giebułtowicz (Warszawa), J. Baran (Warszawa), A. Sikorska (Warszawa), D. Gralak-Łachowska (Warszawa), M. Soszyńska (Warszawa), M. Misiewicz (Warszawa), E. Błachnio (Warszawa), P. Wroczyński (Warszawa), P. Kułakowski (Warszawa, Rzeszów)

Peripheral chemoreceptors' blockade abolishes asphyxia-induced hypertension
S. Tubek (Wrocław), J. Kręcicki (Wrocław), P. Niewiński (Wrocław), B. Paleczny (Wrocław), W. Banasiak (Wrocław), P. Ponikowski (Wrocław)

Inflammatory markers of the postpericardiotomy syndrome
M. Jaworska-Wilczyńska (Warszawa), T. Hryniewiecki (Warszawa)

The omparison of unipolar and bipolar ablation on transmurality of the lesion
A. Baszko (Poznań)

New biomarkers in heart failure

New biomarkers in heart failure

Moderator: M. Kasztura (Wrocław)
Moderator: M. Kałużna-Oleksy (Poznań)

Iron status in patients with heart failure with reduced ejection fraction with ischaemic versus non-ischaemic aetiology
M. Drozd (Wrocław), M. Kasztura (Wrocław), K. Węgrzynowska-Teodorczyk (Wrocław), P. Rozentryt (Zabrze), L. Poloński (Zabrze), J. Małyszko (Białystok), E. Koc-Żórawska (Białystok), W. Banasiak (Wrocław), P. Ponikowski (Wrocław), E. Jankowska (Wrocław)

An assessment of the frequency of lymphocytes with IL-4 intracellular expression and IL-4 concentration in the plasma of patients with idiopathic dilated cardiomyopathy depending on the occurrence of Epstein-Barr virus DNA in PBM cells
D. Stettner-Leonkiewicz (Lublin), E. Grywalska (Lublin), J. Roliński (Lublin), A. Wysokiński (Lublin)

Different clinical profile of patients with heart failure with reduced ejection fraction with low hepcidin versus higly soluble transferrin receptor in serum
M. Kasztura (Wrocław), M. Drozd (Wrocław), P. Rozentryt (Zabrze), L. Poloński (Zabrze), J. Małyszko (Białystok), E. Koc-Żórawska (Białystok), J. Majda (Wrocław), W. Banasiak (Wrocław), P. Ponikowski (Wrocław), E. Jankowska (Wrocław)

Fibrosis of extracellular matrix is inversely related with left ventricular volumes in dilated cardiomyopathy
P. Rubiś (Kraków), S. Wiśniowska-Śmiałek (Kraków), L. Rudnicka-Sosin (Kraków), L. Khachatryan (Kraków), A. Karabinowska (Kraków), P. Faltyn (Kraków), E. Dziewięcka (Kraków), B. Biernacka-Fijałkowska (Kraków), A. Kozanecki (Kraków), P. Podolec (Kraków)

High-sensitive cardiac troponin I in diagnosis of early myocardial damage in patients with acute heart failure
R. Zymliński (Wrocław), M. Sokolski (Wrocław), J. Biegus (Wrocław), S. Nawrocka (Wrocław), P. Siwołowski (Wrocław), J. Todd (Alameda), J. Estis (Alameda), S. Florey (Alameda), E. Jankowska (Wrocław), W. Banasiak (Wrocław), P. Ponikowski (Wrocław)

Assesment of percentage of T and B lymphocytes with superficial expression of PD-1 molecule in patients with idiopathic dilated cardiomyopathy
D. Stettner-Leonkiewicz (Lublin), E. Grywalska (Lublin), J. Roliński (Lublin), A. Wysokiński (Lublin)

Chronic heart failure induces changes in the serum blood profile of lipids containing choline – results of the validation study
M. Marcinkiewicz-Siemion (Białystok), K. Ptaszyńska-Kopczyńska (Białystok), M. Ciborowski (Białystok), A. Szpakowicz (Białystok), A. Lisowska (Białystok), M. Jasiewicz (Białystok), E. Waszkiewicz (Białystok), A. Krętowski (Białystok), W. Musiał (Białystok), K. Kamiński (Białystok)

The correlation between soluble ST2 and inflammatory parameters in patients with stable chronic heart failure
M. Kałużna-Oleksy (Poznań), J. Migaj (Poznań), M. Mróz (Poznań), P. Banasińska (Poznań), E. Straburzyńska-Migaj (Poznań)

Alterations of plasma macrophage migration inhibitory factor (MIF) concentration in patients with chronic heart failure treated with cardiac resynchronization therapy
E. Sawicka (Białystok), K. Ptaszyńska-Kopczyńska (Białystok), M. Marcinkiewicz-Siemion (Białystok), A. Lisowska (Białystok), M. Witkowski (Białystok), K. Charkiewicz (Białystok), P. Laudański (Białystok), W. Musiał (Białystok), K. Kamiński (Białystok)

Increased levels of urinary biomarkers of tubular injury as a predictor of poor diuretic response in acute heart failure
M. Sokolski (Wrocław), R. Zymliński (Wrocław), J. Biegus (Wrocław), P. Siwołowski (Wrocław), J. Krzysztofik (Wrocław), J. Todd (Alameda), J. Estis (Alameda), E. Jankowska (Wrocław), W. Banasiak (Wrocław), P. Ponikowski (Wrocław)

Early changes of biochemical markers of heart failure and myocardial injury after electrical cardioversion of atrial fibrillation
P. Abramczyk (Warszawa), J. Słomka (Warszawa), A. Kaczyńska (Warszawa), M. Siński (Warszawa), J. Lewandowski (Warszawa), I. Nawrocka (Warszawa)

Prevention of cardiovascular diseases: risk factors

Prevention of cardiovascular diseases: risk factors

Moderator: R. Topór-Mądry (Kraków)
Moderator: D. Śliż (Warszawa)

Ten-year changes in risk SCORE in Polish population resulting from WOBASZ surveys analysis
W. Piotrowski (Warszawa), M. Polakowska (Warszawa), A. Cicha-Mikołajczyk (Warszawa), W. Bielecki (Łódź), K. Kozakiewicz (Katowice), A. Pająk (Kraków), A. Tykarski (Poznań), T. Zdrojewski (Gdańsk, Warszawa), W. Drygas (Warszawa)

Psychosocial risk factors of cardiovascular diseases in adult Polish population. What changed during last 10 years? – results of two national surveys: WOBASZ and WOBASZ II
J. Piwoński (Warszawa), A. Piwońska (Warszawa), P. Kurjata (Warszawa), W. Drygas (Warszawa), W. Bielecki (Łódź), K. Kozakiewicz (Katowice), A. Pająk (Kraków), A. Tykarski (Poznań), T. Zdrojewski (Gdańsk, Warszawa)

Smoking habit in Polish population. Results of WOBASZ II survey
M. Polakowska (Warszawa), W. Piotrowski (Warszawa), W. Drygas (Warszawa), W. Bielecki (Łódź), K. Kozakiewicz (Katowice), A. Pająk (Kraków), A. Tykarski (Poznań), T. Zdrojewski (Gdańsk, Warszawa)

Trends in the incidence and 12-month mortality in patients hospitalized for cardiovascular diseases in 2006‒2014. Silesian Cardiovascular Database
M. Gąsior (Zabrze), D. Pres (Zabrze), W. Wojakowski (Katowice), P. Buszman (Katowice), Z. Kalarus (Zabrze), M. Hawranek (Zabrze), E. Nowalany-Kozielska (Zabrze), A. Lekston (Zabrze), Z. Gąsior (Katowice), K. Mizia-Stec (Katowice), K. Milewski (Katowice), M. Zembala (Zabrze), K. Wita (Katowice), L. Poloński (Zabrze), M. Tendera (Katowice)

The quality of diet of the adult Polish population – WOBASZ II project
A. Waśkiewicz (Warszawa), A. Aranowska (Warszawa), U. Stepaniak (Kraków), A. Pająk (Kraków), D. Szostak-Węgierek (Warszawa), M. Kwaśniewska (Łódź), M. Zujko (Białystok), T. Zdrojewski (Gdańsk, Warszawa), A. Tykarski (Poznań), K. Kozakiewicz (Katowice), W. Drygas (Warszawa)

Does the place of residence determine the amount of food products important to the prevention of cardiovascular disease consumed? Results of the WOBASZ II Project
A. Aranowska (Warszawa), A. Waśkiewicz (Warszawa), D. Szcześniewska (Warszawa), W. Bielecki (Łódź), K. Kozakiewicz (Katowice), A. Pająk (Kraków), A. Tykarski (Poznań), T. Zdrojewski (Gdańsk, Warszawa), W. Drygas (Warszawa)

12:45 - 14:15

Combined therapy for treatment of dyslipidemia in new ESC guidelines

Combined therapy for treatment of dyslipidemia in new ESC guidelines

Satellite session organized by MSD

Chairpersons: A. Gitt (Ludwigshafen)

Why do we need combined therapy?
Z. Kalarus (Zabrze)

Combined therapy – what is new in 2016 ESC guidelines?
P. Jankowski (Kraków)

Practical application of combined therapy
A. Gitt (Ludwigshafen)

Cardiology of 21st: more expensive or cheaper? Experts debate

Cardiology of 21st: more expensive or cheaper? Experts debate

Satellite session organized by Abbott

Chairpersons: P. Hoffman (Warszawa)
Chairpersons: M. Zembala (Zabrze)
Moderator: P. Schramm (Warszawa)

Opening

Interventional cardiology – how medical technologies improve long-term prognosis for patients?
D. Dudek (Kraków)

Modern clinical diagnosis in ACS
C. Liebetrau (Bad Nauheim)

Clinical effectiveness & cost-effectiveness of modern technologies – a key element in selection of therapy?
M. Niewada (Warszawa)

Experts debate
P. Schramm (Warszawa)

Take home message

Women, wine and signing – opportunities and challenges in contemporary cardiology

Women, wine and signing – opportunities and challenges in contemporary cardiology

Satellite session organized by KRKA

Chairpersons: K. Filipiak (Warszawa)

Cardioprotection in practice – pharmacological and non-pharmacological
K. Filipiak (Warszawa)

What do women want and what they need – in the eyes of cardiologist
M. Klocek (Kraków)

Music soothes the savage breast – but does it also work on cardiovascular system?
A. Prejbisz (Warszawa)

Essentials for the practitioner of 21st century

Essentials for the practitioner of 21st century

Satellite session organized by Servier

Chairpersons: W. Banasiak (Wrocław)

Myocardial infarction, revascularization and what’s next…?
S. Grajek (Poznań)

ESC HF 2016 Guidelines – what’s new for the practitioners
P. Ponikowski (Wrocław)

A patient from my practice – when guidelines meet practice
J. Nessler (Kraków)

Discussion panel with all the lecturers

New Era of Anticoagulation

New Era of Anticoagulation

Satellite session organized by Boehringer-Ingelheim

Chairpersons: P. Mitkowski (Poznań)

Are all NOACs the same?
J. Stępińska (Warszawa)

New possibilities of anticoagulation reversal
A. Tomaszuk-Kazberuk (Białystok)

Experts’ panel discussion
J. Stępińska (Warszawa), A. Słowik (Kraków), P. Pruszczyk (Warszawa), A. Tomaszuk-Kazberuk (Białystok), R. Drwiła (Kraków)

14:30 - 16:00

Coronary disease – progress through the imaging

Coronary disease – progress through the imaging

Satellite session organized by SIEMENS

Chairpersons: M. Dziuk (Warszawa)
Chairpersons: P. Lipiec (Łódź)
Chairpersons: M. Kruk (Warszawa)

Echocardiography
J. Kasprzak (Łódź)

Nuclear cardiology
M. Dziuk (Warszawa)

Computed tomography
C. Kępka (Warszawa)

Magnetic resonance
M. Pyda (Poznań)

Angiography
A. Witkowski (Warszawa)

Novelty in pharmacological treatment of high-risk cardiovascular patients

Novelty in pharmacological treatment of high-risk cardiovascular patients

Satellite session organized by AstraZeneca

Chairpersons: D. Dudek (Kraków)

Why do we have to use antiplatelet therapy for 12 months after an acute coronary syndrome? – latest scientific evidence
D. Dudek (Kraków)

Innovative diabetes treatments – variety of benefits for every patients with type 2 diabetes
K. Pawlaczyk (Poznań)

ARNI in chronic systolic heart failure – compendium of practitioner physician

ARNI in chronic systolic heart failure – compendium of practitioner physician

Satellite session organized by Novartis

Chairpersons: J. Nessler (Kraków)

Improving the prognosis of patients with chronic systolic heart failure – PARADIGM-HF research result
J. Stępińska (Warszawa)

Practical aspects of dosing ARNI to patient with HFrEF
M. Lelonek (Łódź)

Safety of sacubitrilum/valsartan pharmacotherapy in clinical practice
P. Rozentryt (Zabrze)

"Better to ask the way than go astray" – series of frequently asked questions in the area of hypercholesterolemia, hypertension, heart failure and pain treatment

"Better to ask the way than go astray" – series of frequently asked questions in the area of hypercholesterolemia, hypertension, heart failure and pain treatment

Satellite session organized by Sandoz

Chairpersons: A. Mamcarz (Warszawa)

Wykładowcy
M. Chrostowska (Gdańsk), M. Grabowski (Warszawa), S. Grajek (Poznań), P. Rozentryt (Zabrze), J. Woroń (Kraków)

Ancient philosophy and contemporary cardiology: one can never step in the same river twice

Ancient philosophy and contemporary cardiology: one can never step in the same river twice

Satellite session organized by Berlin-Chemie Menarini

Chairpersons: K. Filipiak (Warszawa)

Introduction
K. Filipiak (Warszawa)

When, in optimal manner, the antihypertensive therapy should be started, and with which drug?
B. Okopień (Katowice)

When, in optimal manner, the cardioprotective treatment in patient with CAD should be started, and with which drug?
G. Opolski (Warszawa)

When, in optimal manner, the cardioprotective treatment in patient with HF should be started, and with which drug?
P. Hoffman (Warszawa)

Summary
K. Filipiak (Warszawa)

Oral anticoagulation considering the new ESC Atrial Fibrillation Guidelines 2016

Oral anticoagulation considering the new ESC Atrial Fibrillation Guidelines 2016

Satellite session organized by Pfizer

Chairpersons: A. Budaj (Warszawa)
Chairpersons: Z. Kalarus (Zabrze)

Cardiologist’s perspective
Z. Kalarus (Zabrze)

Coagulation expert’s perspective
A. Undas (Kraków)

Neurologist’s perspective
A. Słowik (Kraków)

Wrap-up and discussion

Adherence in cardiology
A. Tykarski (Poznań)

New adherence-supporting technologies
P. Balsam (Warszawa)

16:30 - 18:00

Update on heart valves

Update on heart valves

French-German-Polish session

Chairpersons: A. Vahanian (Paryż)
Chairpersons: K. Kuck (Hamburg)
Chairpersons: P. Hoffman (Warszawa)

Does MitraClip affect mortality in patients with secondary MR?
P. Ponikowski (Wrocław)

Percutaneous annuloplasty in patients with secondary MR
K. Kuck (Hamburg)

TAVR vs. SAVR in patients with aortic stenosis and moderate risks
A. Vahanian (Paryż)

Athlete's heart – adaptation or also pathology?

Athlete's heart – adaptation or also pathology?

Chairpersons: W. Braksator (Warszawa)
Chairpersons: A. Mamcarz (Warszawa)

ECG, athlete's heart – interpretation of current guidelines
M. Kuch (Warszawa)

Athlete's heart, arrhythmia is more common, especially atrial fibrillation – facts and myths
I. Cygankiewicz (Łódź)

Does a marathon harm the heart? Impact of strength and extreme effort on the heart
E. Biernacka (Warszawa)

The role of genetics in sport – who can run sprint, who can run a marathon, and who's out?
Z. Gaciong (Warszawa)

Echo stress – additional helpful tool for decision-making

Echo stress – additional helpful tool for decision-making

Chairpersons: M. Kowalski (Warszawa)
Chairpersons: J. Kasprzak (Łódź)
Chairpersons: K. Mizia-Stec (Katowice)

Patient with dyspnea in diabetes
W. Kosmala (Wrocław)

Patient with asymptomatic severe heart failure
D. Sorysz (Kraków)

Patient with simulator and discomfort in the chest
E. Płońska-Gościniak (Szczecin)

Patient with symptoms but unconfirmed heart failure
P. Lipiec (Łódź)

Difficult cases of heart defects. What did they teach us – continuum

Difficult cases of heart defects. What did they teach us – continuum

Chairpersons: G. Brzezińska-Rajszys (Warszawa)
Chairpersons: B. Maruszewski (Warszawa)
Chairpersons: J. Różański (Warszawa)

Waiting for the heart – long-term support of ECMO as a bridge to transplant – a challenge for the Heart Team
P. Litwiński, M. Demkow (Warszawa)

Palliative treatment of patient with cyanotic congenital heart disease – have we reached a therapeutic dead end?
J. Kusa (Wrocław), J. Rycaj

Coronary arteries fistulas – interventions or surgeries?
R. Sabiniewicz (Gdańsk), P. Potaż (Gdańsk)

Guidelines in electrophysiology and electrotherapy

Guidelines in electrophysiology and electrotherapy

Session recommended by Scientific Committee for PCS Congresses

Chairpersons: P. Mitkowski (Poznań)
Chairpersons: J. Kaźmierczak (Szczecin)

ICD therapy
O. Kowalski (Zabrze)

CRT therapy
M. Kempa (Gdańsk)

Lead-dependent endocarditis
M. Grabowski (Warszawa)

ICD – programming and testing
M. Sterliński (Warszawa)

Repolarization – the ECG trash or how to see important abnormalities

Repolarization – the ECG trash or how to see important abnormalities

Chairpersons: R. Ochotny (Poznań)
Chairpersons: J. Wranicz (Łódź)

Normal repolarization pattern and non-cardiac factors affecting the repolarization pattern
M. Mączewski (Warszawa)

Genetically determined repolarization abnormalities
P. Kukla (Gorlice)

Secondary repolarization abnormalities caused by cardiac factors
R. Baranowski (Warszawa)

How to recognise features of ischaemia correctly?
J. Sacha (Opole)

Advances in the treatment of myocardial infarction complicated by cardiogenic shock

Advances in the treatment of myocardial infarction complicated by cardiogenic shock

The joint session of the PCS Working Group on Cardiac Intensive Care and Resuscitation and the PCS Association Group on Cardiovascular Interventions

Chairpersons: B. Sobkowicz (Białystok)
Chairpersons: J. Legutko (Kraków)

Myocardial revascularization
W. Wojakowski (Katowice)

Mechanical circulatory support (IABP, LVAD, ECMO)
D. Dudek (Kraków)

Therapeutic hypothermia after sudden cardiac arrest
B. Średniawa (Zabrze)

Intensive cardiac care
J. Stępińska (Warszawa)

Cardiac surgery treatment
M. Kuśmierczyk (Warszawa)

Treatment of the myocardial infarction complicated by cardiogenic shock in Poland
M. Gąsior (Zabrze)

Advanced heart failure – what can be done better?

Advanced heart failure – what can be done better?

Session recommended by the Scientific Committee for PCS Congresses

Chairpersons: P. Ponikowski (Wrocław)
Chairpersons: J. Nessler (Kraków)

Congestion and euvolemia
E. Nowalany-Kozielska (Zabrze)

Organ hypoperfusion
R. Zymliński (Wrocław)

Ventricular arrhythmia
Z. Kalarus (Zabrze)

Which patient should be considered for mechanical circulatory support and heart transplantation?
T. Zieliński (Warszawa)

The role of a cardiologist in the treatment of atherosclerosis

The role of a cardiologist in the treatment of atherosclerosis

Chairpersons: A. Witkowski (Warszawa)
Chairpersons: A. Sieroń (Bytom)
Discussion panel: P. Pieniążek (Kraków)
Discussion panel: M. Chyrchel (Kraków)
Discussion panel: T. Przewłocki (Kraków)
Discussion panel: M. Lesiak (Poznań)
Discussion panel: R. Gil (Warszawa)

Prevention of vascular diseases according to guidelines of scientific associations for patients with multilevel atherosclerosis
R. Parma (Katowice)

Intermittent claudication and atherosclerosis of lower extremities - prognosis for patients with multilevel atherosclerosis
S. Bartuś (Kraków)

Prognosis for patients with critical limb ischaemia – possible therapeutic perspectives
F. Pukacki (Poznań)

Atherosclerotic occlusive of the aortic arch and the treatment of coronary heart disease – dilemmas of a cardiologist and a cardiac surgeon
P. Musiałek (Kraków)

Interventions in the area of renal arteries as a therapeutic option for advanced heart diseases – new therapeutic opportunities
J. Kądziela (Warszawa)

Panel discussion: the role of a cardiologist in specialised teams dealing with prevention and treatment of vascular diseases

Prognostic factors in congestive heart failure

Prognostic factors in congestive heart failure

Chairpersons: E. Straburzyńska-Migaj (Poznań)
Chairpersons: K. Kamiński (Białystok)

The impact of severe mitral insufficiency on outcome and treatment qualification in systolic heart failure patients
Ł. Pyka (Zabrze), A. Kurek (Zabrze), A. Krajewski (Zabrze), M. Hawranek (Zabrze), M. Tajstra (Zabrze), M. Gierlotka (Zabrze), A. Lekston (Zabrze), M. Zembala (Zabrze), M. Gąsior (Zabrze)

Long-term prognosis in population of Polish patients with heart failure and atrial fibrillation in the European Society of Cardiology heart failure long-term registry
M. Kluk (Kielce), R. Bartkowiak (Kielce), B. Sosnowska-Pasiarska (Kielce), B. Wożakowska-Kapłon (Kielce), G. Opolski (Warszawa), P. Ponikowski (Wrocław), L. Poloński (Zabrze), J. Drożdż (Łódź)

Impact of a chronic total occlusion of the coronary artery on long-term prognosis in patients with ischemic systolic heart failure – insights from contemporary modalities In treatment of heart failure (COMMIT-HF) registry
M. Tajstra (Zabrze), Ł. Pyka (Zabrze), J. Gorol (Zabrze), M. Gierlotka (Zabrze), D. Pres (Zabrze), E. Gadula-Gacek (Zabrze), A. Kurek (Zabrze), M. Hawranek (Zabrze), A. Lekston (Zabrze), L. Poloński (Zabrze), M. Gąsior (Zabrze)

Abnormal erythropoietin level in anaemic patients with heart failure is related to disease severity and renal impairment, but do not correlate neither with inflammation nor with iron deficiency
M. Tkaczyszyn (Wrocław), P. Van Der Meer (Groningen), I. Flinta (Wrocław), C. Enjuanes (Barcelona), W. Banasiak (Wrocław), A. Voors (Groningen), P. Ponikowski (Wrocław), J. Comin-Colet (Barcelona), E. Jankowska (Wrocław)

Summary – prognostic factors in a congestive heart failure
E. Straburzyńska-Migaj (Poznań)

Cardiac injury in complications of influenza. Prevention or therapy?

Cardiac injury in complications of influenza. Prevention or therapy?

The session of Polish National Programe for Influenza Prevention

Chairpersons: A. Antczak (Łódź)
Chairpersons: K. Gołba (Katowice)

Cardiovascular complications of influenza. Presentation of clinical cases
J. Biernat (Katowice)

Influenza as a factor initiating acute coronary syndrome (ACS)
A. Ciszewski (Warszawa)

Current indications in application of influenza prevention among cardiac patients
P. Jankowski (Kraków)

Can we expect vaccines against hypertension and arthrosclerosis in the future?
T. Guzik (Kraków)

What is new in treatment and diagnostics of patients with congenital cardiac defect

What is new in treatment and diagnostics of patients with congenital cardiac defect

Chairpersons: L. Tomkiewicz-Pająk (Kraków)
Chairpersons: M. Szkutnik (Zabrze)

Hypokalemia in adults with atrial septal defect – prevalence and relation to arrhythmia
M. Komar (Kraków), T. Przewłocki (Kraków), B. Sobień (Kraków), M. Olszowska (Kraków), L. Tomkiewicz-Pająk (Kraków), P. Wilkołek (Kraków), M. Hlawaty (Kraków), P. Prochownik (Kraków), P. Podolec (Kraków)

Late gadolinium enhancement and exercise capacity in adults with Ebstein's anomaly
A. Ciepłucha (Poznań), O. Trojnarska (Poznań), A. Kociemba (Poznań), M. Łanocha (Poznań), M. Pyda (Poznań), M. Barczyński (Poznań), S. Grajek (Poznań)

Investigating the purview of Melody valve implantation for the pediatric population – an alluring option
S. Góreczny (Łódź), P. Dryżek (Łódź), J. Moll (Łódź), A. Krawczuk (Łódź), J. Moll (Łódź), T. Moszura (Łódź)

Early experience with novel three-dimensional image fusion software for guidance of complex cardiac catheterizations in patients with congenital heart defects
S. Góreczny (Łódź), P. Dryżek (Łódź), M. Łukaszewski (Łódź), A. Hul (Łódź), J. Moll (Łódź), T. Moszura (Łódź)

Summary – what is new in diagnostics and treatment of patients with congenital cardiac defects
A. Klisiewicz (Warszawa)

Heart failure as a cardiogeriatric syndrome

Heart failure as a cardiogeriatric syndrome

Chairpersons: K. Josiak (Wrocław)
Chairpersons: P. Leszek (Warszawa)

Comprehensive assessment of an elderly patient with heart failure
B. Gryglewska (Kraków)

Therapy of co-morbidities in an elderly patient with heart failure
E. Jankowska (Wrocław)

Specific features of pharmacotherapy of an elderly patient with heart failure
T. Grodzicki (Kraków)

Cardiac surgery

Cardiac surgery

Moderator: M. Krejca (Katowice)
Moderator: J. Rogowski (Gdańsk)

The impact of infection on long term outcomes in patients with a continuous-flow left ventricular assist device (CF-LVAD) – Zabrze experience
R. Antończyk (Zabrze), J. Pacholewicz (Zabrze), M. Sioła (Zabrze), M. Zakliczyński (Zabrze), M. Zembala (Zabrze)

The comparison of hepatic dysfunction based on MELD-XI score in patients underwent bicaval and biatrial techniques for heart transplant. One-year observation
B. Szyguła-Jurkiewicz (Zabrze), J. Pacholewicz (Zabrze), K. Filipiak (Zabrze), N. Kamieńska (Zabrze), P. Nadziakiewicz (Zabrze), M. Skrzypek (Katowice), W. Szczurek (Zabrze), M. Zakliczyński (Zabrze), M. Gąsior (Zabrze), M. Zembala (Zabrze)

Pitfalls in frailty assessment in cardiac surgery-comparison of two diagnostic tools
A. Wiórek (Zabrze), M. Stankiewicz (Zabrze), A. Kowalczuk (Zabrze), Ł. Krzych (Zabrze)

Value of prognostic geriatric’s scale in estimate of risk of complications in patients ≥70 years of age after cardiosurgery treatment
A. Kowalczuk (Zabrze), I. Jaworska (Zabrze), J. Foremny (Zabrze), R. Przybylski (Zabrze), R. Przybylski (Zabrze), M. Zembala (Zabrze)

The assessment of complications in patients ≥75 years of age underwent cardiac surgeries in the centre in Zabrze over the period 2010‒2012
J. Foremny (Zabrze), A. Kowalczuk (Zabrze), I. Jaworska (Zabrze), M. Zembala (Zabrze)

First in human safety study of micronized extracellular matrix implantation in post-infarction ischemic heart failure
P. Suwalski (Warszawa), R. Smoczyński (Warszawa), S. Sypuła (Warszawa), M. Furmanek (Warszawa), D. Drobiński (Warszawa), A. Witkowska (Warszawa), J. Staromłyński (Warszawa)

Early and late clinical outcomes of patients with heavily calcified coronary artery lesions treated with coronary artery bypass grafting
M. Kosowski (Wrocław), W. Zimoch (Wrocław), P. Kubler (Wrocław), A. Kuc (Wrocław), B. Tomasiewicz (Wrocław), J. Kulczycki (Wrocław), M. Biela (Wrocław), J. Skiba (Wrocław), K. Reczuch (Wrocław)

Does the abnormal level of HbA1c or fructosamine have influance on postsurgical complcations after CABG in diabetic patients?
A. Kowalczuk (Zabrze), I. Majchrzyk (Zabrze), J. Foremny (Zabrze), M. Parys (Zabrze), M. Zembala (Zabrze)

Red blood cell count as a prognostic marker in patients undergoing heart valve surgery
P. Duchnowski (Warszawa), T. Hryniewiecki (Warszawa), M. Kuśmierczyk (Warszawa), P. Szymański (Warszawa)

The comparison of totally thoracoscopic transareolar mitral and tricuspid valve repair and right-sided minithoracotomy
R. Smoczyński (Warszawa), J. Staromłyński (Warszawa), A. Witkowska (Warszawa), D. Drobiński (Warszawa), P. Suwalski (Warszawa)

Cardiac and vascular imaging

Cardiac and vascular imaging

Moderator: T. Kukulski (Zabrze)

Cardiovascular dysfunction in patients with systemic sclerosis
K. Gieszczyk-Strózik (Katowice), E. Kucharz (Katowice), M. Widuchowska (Katowice), K. Mizia-Stec (Katowice), A. Sikora-Puz (Katowice), M. Mizia (Katowice)

3-dimensional over 2-dimensional transesophageal echocardiography in selection of occluders for percutaneous left atrial closure
W. Streb (Zabrze), K. Mitręga (Zabrze), M. Szymała (Zabrze), T. Podolecki (Zabrze), G. Mencel (Zabrze), Z. Kalarus (Zabrze)

Hemodynamic indices of the left atrium as predictors of maintenance of sinus rhythm after cardioversion for persistent non-valvular atrial fibrillation – a prospective study
T. Zapolski (Lublin), A. Kamińska (Lublin), Ł. Konarski (Lublin), A. Wysokiński (Lublin)

Baseline renal resistive index accurately predicts contrast-induced acute kidney injury after coronary angiography in patients with coronary artery disease and initially preserved renal function
M. Wybraniec (Katowice), K. Mizia-Stec (Katowice), M. Bożentowicz-Wikarek (Katowice), J. Chudek (Katowice)

Analysis of the significance of ultrasonographic renal blood flow parameters for the prediction of contrast-induced acute kidney injury after coronary angiography
M. Wybraniec (Katowice), J. Chudek (Katowice), M. Bożentowicz-Wikarek (Katowice), K. Mizia-Stec (Katowice)

Impact of carotid artery revascularization on the cognitive and functional outcome, as well as cerebral flow on TCD and brain MRI in patients with symptomatic carotid artery stenosis: a preliminary report
R. Badacz (Kraków), A. Kabłak-Ziembicka (Kraków), M. Urbańczyk-Zawadzka (Kraków), R. Banyś (Kraków), P. Musiałek (Kraków), P. Pieniążek (Kraków), M. Trystuła (Kraków), S. Mleczko (Kraków), A. Rosławiecka (Kraków), D. Rzeźnik (Kraków), A. Brzychczy (Kraków), K. Żmudka (Kraków), T. Przewłocki (Kraków)

Tomographic predictors of side branch compromise after percutaneous coronary intervention in bifurcation lesions
R. Wolny (Warszawa), J. Pręgowski (Warszawa), A. Witkowski (Warszawa)

Pocket-size imaging devices in the initial assessment of patients with suspected pulmonary embolism
D. Filipiak (Łódź), J. Kasprzak (Łódź), P. Lipiec (Łódź)

Higher values of left ventricular apical rotation and twist in patients with severe aortic valve stenosis compared with controls
K. Wierzbowska-Drabik (Łódź), A. Mielczarek (Łódź), P. Lipiec (Łódź), J. Kasprzak (Łódź)

SYNTAX and GENSINI score correlation with left ventricular global systolic strain at rest and during peak stage of dobutamine stress echocardiography (DSE)
K. Wierzbowska-Drabik (Łódź), M. Simiera (Łódź), M. Plewka (Łódź), J. Kasprzak (Łódź)

Cognitive and clinical value of the hemodynamic assessment by impedance cardiography in Cushing's disease
A. Jurek (Warszawa), P. Krzesiński (Warszawa), P. Witek (Warszawa), G. Zieliński (Warszawa), G. Gielerak (Warszawa), A. Skrobowski (Warszawa)

Exercise echocardiography in patients with exercise intolerance and lower intermediate pretest probability of coronary artery disease
B. Zaborska (Warszawa), K. Smarż (Warszawa), E. Pilichowska-Paszkiet (Warszawa), M. Sikora-Frąc (Warszawa), A. Budaj (Warszawa)

Prevention of cardiovascular diseases: prognostic factors

Prevention of cardiovascular diseases: prognostic factors

Moderator: D. Szalewska (Gdańsk)
Moderator: A. Januszewicz (Warszawa)
Moderator: A. Serafin (Warszawa)

Every second patient with cardiac resynchronization device-related infective endocarditis does not leave hospital alive – what are the mortality predictors of this life-threatening condition?
M. Mazurek (Zabrze), E. Jędrzejczyk-Patej (Zabrze), O. Kowalski (Zabrze), A. Sokal (Zabrze), S. Pluta (Zabrze), M. Kozieł (Zabrze), K. Adamczyk (Zabrze), A. Liberska (Zabrze), K. Przybylska (Zabrze), S. Morawski (Zabrze), M. Szulik (Zabrze), T. Podolecki (Zabrze), J. Kowalczyk (Zabrze), Z. Kalarus (Zabrze), R. Lenarczyk (Zabrze)

The relationship between walking abilities, endothelial function and prostanoids release in patients with peripheral artery disease (PAD) undergoing supervised training treadmill program (STTP)
R. Januszek (Kraków), P. Mika (Kraków), R. Nowobilski (Kraków), P. Maga (Kraków), R. Niżankowski (Kraków)

Blood pressure in relation to 24-hour urinary sodium excretion and renal sodium handling
K. Stolarz-Skrzypek (Kraków), A. Bednarski (Kraków), A. Franczyk (Kraków), H. Bartoń (Kraków), A. Olszanecka (Kraków), M. Kloch-Badełek (Kraków), G. Kiełbasa (Kraków), K. Kawecka-Jaszcz (Kraków), D. Czarnecka (Kraków)

How the risk of cardiovascular death depends on the socioeconomic status?
P. Nadrowski (Katowice), K. Kozakiewicz (Katowice), E. Podolecka (Katowice), A. Pająk (Kraków), W. Drygas (Warszawa), W. Bielecki (Łódź), A. Tykarski (Poznań), T. Zdrojewski (Gdańsk, Warszawa), M. Skrzypek (Katowice), W. Wojakowski (Katowice)

Relationship between concentrations of vasopressin and natriuretic peptydes as a prognostic factor of patients after cardiac arrest
Z. Sablik (Łódź), A. Samborska-Sablik (Łódź), T. Gaszyński (Łódź), J. Drożdż (Łódź)

Does the presence of selected modifiable risk factors increase the chance for the awareness of their contribution to the pathogenesis of coronary heart disease and erectile dysfunction in a group of patients with CHD and ED?
D. Kałka (Wrocław), W. Pilecki (Wrocław), A. Grychowski (Głuchołazy), Z. Domagała (Wrocław), J. Gebala (Wrocław), L. Rusiecki (Wrocław), A. Dulanowska (Wrocław), K. Stolarczyk (Wrocław), J. Dulanowski (Wrocław), K. Womperski (Głuchołazy)

Improvement of left ventricular function after percutaneous coronary intervention in patients with stable coronary artery disease and preserved ejection fraction
M. Sikora-Frąc (Warszawa), B. Zaborska (Warszawa), P. Maciejewski (Warszawa), B. Bednarz (Warszawa), A. Budaj (Warszawa)

Carotid intima-media thickness as an early marker of atherosclerosis and brachial artery flow mediated dilatation-endothelial function in patients with mild and moderate psoriasis
K. Bańska (Katowice), M. Matla (Katowice), B. Bergler-Czop (Katowice), L. Brzezińska-Wcisło (Katowice), B. Hapeta (Katowice), M. Haberka (Katowice), Z. Gąsior (Katowice)

Factors determinig exercise capacity evaluated during cardiopulmonary exercise testing in 6-month follow up after ST elevation myocardial infarction
M. Turski (Katowice), A. Berger-Kucza (Katowice), K. Mizia-Stec (Katowice), K. Wita (Katowice)

18:15 - 18:55

Meeting of Reviewers, Scientific Board and Board of Editors of the „Polish Heart Journal”

Meeting of Reviewers, Scientific Board and Board of Editors of the „Polish Heart Journal”

Awarding statuettes for the most frequently citing and cited authors

Chairpersons: K. Filipiak (Warszawa)
Chairpersons: B. Bednarz (Warszawa)
Chairpersons: U. Grochowicz (Warszawa)

Saturday

17

September
SALA 1 SALA 2 SALA 3 SALA 4 SALA 5 SALA 6 SALA 7 SALA 8 SALA 9 SALA 10 SALA 11 SALA 12 SALA 13 SALA Sesje plakatowe
09:00 - 10:30

Acute failure of the right ventricle

Acute failure of the right ventricle

Chairpersons: J. Stępińska (Warszawa)
Chairpersons: P. Rozentryt (Zabrze)

High risk acute pulmonary embolism
M. Ciurzyński (Warszawa)

Advanced pulmonary hypertension
M. Kurzyna (Otwock)

Right ventricular myocardial infarction
A. Tycińska (Białystok)

Acute right ventricular failure in cardiac surgery and heart transplantation
E. Kucewicz-Czech (Zabrze)

Management optimalization in STEMI

Management optimalization in STEMI

Chairpersons: J. Kubica (Bydgoszcz)
Chairpersons: A. Budaj (Warszawa)

Complete revascularization is an optimal intervention in STEMI
Pro: P. Maciejewski (Warszawa)
Contra: J. Legutko (Kraków)

Dual antiplatelet therapy in STEMI should be initiated as early as possible
Pro: W. Kuliczkowski (Wrocław)
Contra: M. Koziński (Bydgoszcz)

Bioresorbable scaffolds for complex coronary lesions

Bioresorbable scaffolds for complex coronary lesions

Chairpersons: Ł. Rzeszutko (Kraków)
Chairpersons: M. Lesiak (Poznań)

Chronic total occlusion CTO
J. Wójcik (Lublin)

Coronary artery bifurcations
M. Grygier (Poznań)

Calcified lesions
S. Dobrzycki (Białystok)

Acute coronary syndrome
M. Gąsior (Zabrze)

In-stent restenosis
J. Kochman (Warszawa)

My patient with an implanted device

My patient with an implanted device

Chairpersons: P. Mitkowski (Poznań)
Chairpersons: M. Sterliński (Warszawa)

Has indications for MRI
J. Bednarek (Kraków)

Has indications for oncological radiotherapy
A. Oręziak (Warszawa)

Wants to return to work
J. Blicharz

Wants to do sport
J. Kaźmierczak (Szczecin)

Algorithms for acute heart failure

Algorithms for acute heart failure

Chairpersons: T. Rywik (Warszawa)
Chairpersons: K. Mizia-Stec (Katowice)

How to carry out initial assessment of a patient with ONS in a hospital emergency ward?
A. Gackowski (Kraków)

Who can be discharged? How to plan up further care?
J. Nessler (Kraków)

Who needs to be admitted to an intensive cardiac care unit? How to plan up further care before discharging from a hospital?
P. Ponikowski (Wrocław)

Resistant hypertension – how to diagnose, how to treat?

Resistant hypertension – how to diagnose, how to treat?

Chairpersons: A. Tykarski (Poznań)
Chairpersons: K. Narkiewicz (Gdańsk)

Resistant hypertension – clinical importance and diagnostics
A. Januszewicz (Warszawa)

Optimal combination drug therapy – how to fight with resistance of hypertension?
A. Prejbisz (Warszawa)

Therapeutic compliance – are all patients indeed resistant?
K. Stolarz-Skrzypek (Kraków)

Interventional treatment of resistant hypertension – in which patients is effective?
A. Witkowski (Warszawa)

Patient with heart failure – difficult scenarios, difficult decisions

Patient with heart failure – difficult scenarios, difficult decisions

Chairpersons: E. Płońska-Gościniak (Szczecin)
Chairpersons: G. Gajos (Kraków)

Patient with heart failure and diabetes
M. Lelonek (Łódź)

Patient with heart failure and atrial fibrillation
E. Straburzyńska-Migaj (Poznań)

Patient with severe heart failure and kidney failure
J. Drożdż (Łódź)

How to stay healthy and look young?

How to stay healthy and look young?

Session under the patronage of the Polish Forum for Prevention of Cardiovascular Diseases

Chairpersons: P. Podolec (Kraków)
Chairpersons: G. Kopeć (Kraków)
Discussion panel: A. Pająk (Kraków)
Discussion panel: T. Grodzicki (Kraków)
Discussion panel: F. Szymański (Warszawa)
Discussion panel: A. Sarnecka (Kraków)
Discussion panel: P. Jankowski (Kraków)

Use appropriate stimulants
P. Jankowski (Kraków)

Practice proper physical activity
J. Wolszakiewicz (Warszawa)

Eating with awareness
M. Kozłowska-Wojciechowska (Warszawa)

Discussion with the experts and the press

The heart and the environment

The heart and the environment

Chairpersons: M. Kurpesa (Łódź)
Chairpersons: J. Siebert (Gdańsk)

The impact of air pollution on the cardiovascular system
I. Szadkowska-Stańczyk (Łódź)

The noise as a cardiological risk factor
A. Bortkiewicz (Łódź)

The influence of modern technologies on the cardiovascular system
E. Trzos (Łódź)

Does the heart like shift work?
E. Gadzicka (Łódź)

Interventional treatment of congenital cardiac defects in adults – new future prospects

Interventional treatment of congenital cardiac defects in adults – new future prospects

Chairpersons: G. Brzezińska-Rajszys (Warszawa)
Chairpersons: M. Komar (Kraków)

Transcatheter tricuspid valve-in-valve implantation into a failing surgical bioprosthesis in a high-risk patient
J. Henzel (Warszawa), Z. Dzielińska (Warszawa), M. Konka (Warszawa), M. Dąbrowski (Warszawa), M. Protasiewicz (Wrocław), A. Witkowski (Warszawa), M. Demkow (Warszawa)

Percutaneous closure of an aortopulmonary window using Amplatzer Duct Occluder II: Additional Sizes – the first reported case
K. Zbroński (Zabrze, Warszawa), M. Szkutnik (Zabrze), R. Fiszer (Zabrze), J. Białkowski (Zabrze)

Percutaneous closure of patent foramen ovale in a patient with Ebstein’s anomaly
J. Wójcik (Lublin), R. Gęca (Lublin), A. Tomaszewski (Lublin), M. Wójcik (Lublin)

Pulmonary arterial hypertension in 76-year-old female with huge coronary fistula from LCx to coronary sinus
G. Sobieszek (Lublin), W. Kula (Lublin), B. Olajossy (Lublin), W. Witczak (Lublin), E. Czekajska-Chehab (Lublin)

The importance of interdisciplinary cooperation in improvement of prognosis in patients with cardiovascular diseases

The importance of interdisciplinary cooperation in improvement of prognosis in patients with cardiovascular diseases

Chairpersons: D. Dudek (Kraków)
Chairpersons: P. Hoffman (Warszawa)
Chairpersons: J. Imiela (Warszwa)

When to stop cardiovascular interventions in elderly patients? The cardiologist’s point of view
M. Lesiak (Poznań)

When to stop cardiovascular interventions in elderly patients? The geriatrician's point of view
T. Grodzicki (Kraków)

When in prevention of cardiac causes of stroke an intervention is more effective than pharmacotherapy? The cardiologist’s point of view
T. Przewłocki (Kraków)

When in prevention of cardiac causes of stroke an intervention is more effective than pharmacotherapy? The neurologist’s point of view
M. Karliński (Warszawa)

What should the optimal model of intensive cardiac care look like? The cardiologist’s point of view
R. Depukat (Kraków)

What should the optimal model of intensive cardiac care look like? The anesthesia and intensive care specialist's point of view

Comprehensive cardiac surgeries and endovascular procedures in high-risk patients

Comprehensive cardiac surgeries and endovascular procedures in high-risk patients

Chairpersons: R. Kalawski (Poznań)
Chairpersons: S. Bartuś (Kraków)

Aortic valve reconstuction with autologous pericardium in young patient with parathyroid adenoma and severe regurgitation of bicuspid aortic valve
T. Niklewski (Zabrze), R. Przybylski (Zabrze), S. Ozaki (Tokio), P. Nadziakiewicz (Zabrze), M. Zembala (Zabrze)

Transapical mitral valve in ring implantation after unsuccessful mitral valve repair
R. Kozaryn (Gdańsk), D. Jagielak (Gdańsk), R. Pawlaczyk (Gdańsk), J. Rogowski (Gdańsk)

Carotid artery stenting with the use of proximal neuroprotection device and mesh-covered stent implantation for the treatment of severe, bilateral carotid artery stenosis in a high-risk patient
P. Paluszek (Kraków), P. Pieniążek (Kraków), K. Dzierwa (Kraków), M. Trystuła (Kraków)

Left ventricle assist device supported rotational atherectomy of the highly calcified last remaining vessel in a patient with acute myocardial infarction and reduced left ventricular function
B. Tomasiewicz (Wrocław), M. Ferenc (Bad Krozingen), W. Zimoch (Wrocław), P. Kubler (Wrocław), K. Reczuch (Wrocław)

Novelties and progress in cardiac surgery

Novelties and progress in cardiac surgery

Chairpersons: J. Różański (Warszawa)
Chairpersons: T. Hirnle (Białystok)

Outcomes of surgical treatment of patients with severe ischemic left ventricular dysfunction (EF ≤35%)
T. Hrapkowicz (Zabrze), M. Maruszewski (Zabrze), M. Krasoń (Zabrze), P. Nadziakiewicz (Zabrze), R. Przybylski (Zabrze), M. Zembala (Zabrze), K. Filipiak (Zabrze), M. Zembala (Zabrze)

Totally thoracoscopic left atrial appendage occlusion using novel epicardial clipping system for stroke prevention in high risk patietns
A. Witkowska (Warszawa), P. Stachurski (Warszawa), D. Kosior (Warszawa), D. Drobiński (Warszawa), R. Smoczyński (Warszawa), J. Staromłyński (Warszawa), S. Sypuła (Warszawa), W. Sarnowski (Warszawa), P. Suwalski (Warszawa)

Transapical off-pump mitral valve repair. First experiences with Neochord system in Poland
K. Wróbel (Warszawa), K. Kurnicka (Warszawa), M. Zygier (Warszawa), W. Dyk (Warszawa), R. Wojdyga (Warszawa), D. Zieliński (Warszawa), Z. Juraszyński (Warszawa), B. Lichodziejewska (Warszawa), P. Pruszczyk (Warszawa), A. Biederman (Warszawa)

Why I choose minimally invasive aortic valve replacement? Risk-adjusted comparative analysis of 438 cases
M. Kaczmarczyk (Zabrze), M. Zembala (Zabrze), I. Mokryk (Zabrze), K. Filipiak (Zabrze), J. Wojarski (Zabrze), W. Karolak (Zabrze), R. Przybylski (Zabrze), M. Zembala (Zabrze)

Hybrid approach of percutaneous coronary intervention and minimally invasive aortic valve replacement surgery
J. Stoliński (Kraków), D. Plicner (Kraków), P. Kruszec (Kraków), G. Grudzień (Kraków), J. Andres (Kraków), B. Kapelak (Kraków)

Summary – minimally invasive interventions in cardiac surgery
K. Widenka (Rzeszów)

Treatment aspects of selected cardiac diseases

Treatment aspects of selected cardiac diseases

Moderator: M. Kmiecicka (Warszawa)
Moderator: D. Krówczyńska (Warszawa)

Male patients undergo more difficult and more expensive percutaneous coronary procedures despite younger age
B. Dziki (Poznań), I. Miechowicz (Poznań), P. Iwachów (Poznań), P. Kałmucki (Poznań), A. Szyszka (Poznań), T. Siminiak (Poznań), A. Baszko (Poznań)

The determinants of cath lab cost in patients undergoing coronary angioplasty due to acute coronary syndromes
B. Dziki (Poznań), I. Miechowicz (Poznań), P. Iwachów (Poznań), P. Kałmucki (Poznań), A. Szyszka (Poznań), T. Siminiak (Poznań), A. Baszko (Poznań)

Usefulness of the web-based wireless telemonitoring system in patients with the heart failure treated with the resynchronization therapy – preliminary results from one center
M. Wita (Katowice), M. Orszulak (Katowice), K. Szydło (Katowice), K. Sanecki (Katowice), W. Wróbel (Katowice), K. Waga (Katowice), K. Wita (Katowice), K. Gołba (Katowice), K. Mizia-Stec (Katowice)

X-ray dose analysis during angioplasty procedures in consecutive patients with acute coronary syndromes
P. Iwachów (Poznań), I. Miechowicz (Poznań), B. Dziki (Poznań), P. Kałmucki (Poznań), A. Szyszka (Poznań), A. Baszko (Poznań), T. Siminiak (Poznań)

Electrocardiology

Electrocardiology

Moderator: S. Stec (Warszawa)
Moderator: B. Małecka (Kraków)

What is the background of ST depression in AVNRT and AVRT?
K. Błaszyk (Poznań), Ł. Grydz (Nowa Sól), A. Gwizdała (Poznań), W. Seniuk (Poznań), M. Waśniewski (Poznań), M. Michalak (Poznań), J. Hiczkiewicz (Nowa Sól), S. Grajek (Poznań)

Series of 25 cases of life-threatening arrhythmic events in Wolff-Parkinson-White syndrome
P. Moskal (Kraków), M. Pitak (Kraków), M. Jastrzębski (Kraków), A. Rudziński (Kraków), D. Czarnecka (Kraków)

The variability of the his-to-his intervals is asymmetrical
B. Żuchowski (Poznań), K. Błaszyk (Poznań), J. Piskorski (Zielona Góra), A. Wykrętowicz (Poznań), M. Waśniewski (Poznań), A. Gwizdała (Poznań), W. Seniuk (Poznań), P. Guzik (Poznań)

Atrioventricular block but not left bundle branch block predicts exercise capacity in patients with heart failure with reduced ejection fraction
J. Stępniewski (Kraków), G. Kopeć (Kraków), W. Magoń (Kraków), P. Podolec (Kraków)

Do supraventricular arrhythmias influence prognosis in patients with asymptomatic severe aortic stenosis?
E. Orłowska-Baranowska (Warszawa), R. Baranowski (Warszawa), T. Hryniewiecki (Warszawa)

The influence of class III antiarrhythmic drugs on long-term clinical outcome of electrical storm treatment
S. Morawski (Zabrze), P. Pruszkowska-Skrzep (Zabrze), R. Lenarczyk (Zabrze), O. Kowalski (Zabrze), Z. Kalarus (Zabrze), B. Średniawa (Zabrze)

Heart defects: diagnostics and treatment

Heart defects: diagnostics and treatment

Moderator: O. Trojnarska (Poznań)
Moderator: M. Kowalski (Warszawa)

Improvement of exercise capacity after transcatheter closure of atrial septal defect is affected by tricuspid insufficiency
M. Komar (Kraków), T. Przewłocki (Kraków), B. Sobień (Kraków), P. Wilkołek (Kraków), L. Tomkiewicz-Pająk (Kraków), M. Olszowska (Kraków), J. Podolec (Kraków), P. Prochownik (Kraków), P. Podolec (Kraków)

Red cell distribution width as a prognostic marker in patients undergoing valve surgery
P. Duchnowski (Warszawa), T. Hryniewiecki (Warszawa), M. Kuśmierczyk (Warszawa), P. Szymański (Warszawa)

The benefits of atrial septal defect closure in the elderly
M. Komar (Kraków), T. Przewłocki (Kraków), B. Sobień (Kraków), P. Wilkołek (Kraków), L. Tomkiewicz-Pająk (Kraków), M. Olszowska (Kraków), U. Gancarczyk (Kraków), P. Podolec (Kraków)

Global longitudinal strain changes during exercise in severe asymptomatic aortic stenosis
A. Lech (Warszawa), P. Dobrowolski (Warszawa), A. Klisiewicz (Warszawa), P. Hoffman (Warszawa)

Severe degenerative AS with preserved ejection fraction does not change adipokine serum levels
K. Mizia-Stec (Katowice), M. Mizia (Katowice), A. Sikora-Puz (Katowice), K. Gieszczyk-Strózik (Katowice), T. Bochenek (Katowice), B. Kusz (Katowice)

Exercise tolerance and quality of life of children after arterial switch operation for the transposition of the great arteries
K. Szaflik (Łódź), M. Niwald (Łódź), M. Pierzchała (Łódź), B. Pawłowicz (Łódź), J. Moll (Łódź)

Can perimeter of the defect determine occluder size in transcatheter closure of ostium secundum atrial septal defect?
J. Henzel (Warszawa), M. Konka (Warszawa), A. Wójcik (Warszawa), P. Rudziński (Warszawa), A. Kurowski (Warszawa), A. Klisiewicz (Warszawa), P. Hoffman (Warszawa), M. Demkow (Warszawa)

Chellanges in severe heart failure

Chellanges in severe heart failure

Moderator: M. Sobieszczańska-Małek (Warszawa)
Moderator: B. Szyguła-Jurkiewicz (Zabrze)

Predictors of early and late deaths in patients with no-ACS severe acute heart failure treated by heart failure team in the hybrid cardiac intensive care / intensive care unit – analysis from NYHA IV+ registry
M. Gąsior (Zabrze), M. Ostręga (Zabrze), G. Słonka (Zabrze), A. Kurek (Zabrze), R. Koba (Zabrze), P. Nadziakiewicz (Zabrze), M. Zembala (Zabrze), A. Ciślak (Katowice, Zabrze), P. Knapik (Zabrze), M. Gierlotka (Zabrze)

The overhydration as an atypical effect independent from diuretics treatment in patients with dilated cardiomyopathy
D. Stettner-Leonkiewicz (Lublin), A. Wysokiński (Lublin), W. Załuska (Lublin)

Prognostic significance of multi-organ dysfunction/damage in acute heart failure
R. Zymliński (Wrocław), M. Sokolski (Wrocław), J. Biegus (Wrocław), P. Siwołowski (Wrocław), S. Nawrocka (Wrocław), E. Jankowska (Wrocław), W. Banasiak (Wrocław), P. Ponikowski (Wrocław)

The influence of ventilatory disorders on the early and late prognosis in patients with chronic heart failure exacerbation
A. Kowalczys (Gdańsk), K. Kuziemski (Gdańsk), M. Wirtwein (Gdańsk), R. Gałąska (Gdańsk), J. Wdowczyk (Gdańsk), E. Jassem (Gdańsk), M. Gruchała (Gdańsk)

Clinical characteristics, treatment and outcomes of patients with ischemic and non-ischemic etiology of severe acute heart failure (NYHA IV+ registry)
M. Ostręga (Zabrze), M. Gierlotka (Zabrze), G. Słonka (Zabrze), P. Nadziakiewicz (Zabrze), M. Zembala (Zabrze), M. Gąsior (Zabrze)

Prognostic value of (R)CHADS2 and (R)CHA2DS2-VASc scores in patients with acute heart failure in sinus rhythm – results from the Polish part of the ESC-HF Pilot Survey
P. Rostoff (Kraków), J. Zalewski (Kraków), A. Furman-Niedziejko (Kraków), J. Drożdż (Łódź), J. Nessler (Kraków)

Comparison of results after left ventricular assist device implantation in patients with optimal and borderline echocardiographic assessment of right ventricle function
P. Nadziakiewicz (Zabrze), T. Niklewski (Zabrze), B. Szyguła-Jurkiewicz (Zabrze), J. Pacholewicz (Zabrze), T. Hrapkowicz (Zabrze), J. Borkowski (Zabrze), M. Zembala (Zabrze)

Predictors of severe mitral regurgitation improvement after 6 months of cardiac resynchronization therapy
A. Leopold-Jadczyk (Zabrze), M. Szulik (Zabrze), J. Stabryła-Deska (Zabrze), O. Kowalski (Zabrze), R. Lenarczyk (Zabrze), T. Kukulski (Zabrze), Z. Kalarus (Zabrze)

Device-related infective endocarditis in cardiac resynchronization therapy recipients – single center registry with over 2500 person-years follow up
E. Jędrzejczyk-Patej (Zabrze), M. Mazurek (Zabrze), O. Kowalski (Zabrze), A. Sokal (Zabrze), M. Kozieł (Zabrze), K. Adamczyk (Zabrze), K. Przybylska (Zabrze), S. Morawski (Zabrze), A. Liberska (Zabrze), M. Szulik (Zabrze), T. Podolecki (Zabrze), J. Kowalczyk (Zabrze), Z. Kalarus (Zabrze), R. Lenarczyk (Zabrze)

Heart failure team in real-life conditions – a group effort to optimize treatment of the most complex heart failure patient subpopulation
Ł. Pyka (Zabrze), J. Gorol (Zabrze), A. Kurek (Zabrze), M. Hawranek (Zabrze), M. Tajstra (Zabrze), M. Gierlotka (Zabrze), A. Lekston (Zabrze), M. Zembala (Zabrze), M. Gąsior (Zabrze)

Reverse remodeling of the left ventricle as a sign of regression of uremic cardiomyopathy in patients after renal transplantation – long-term follow-up
T. Zapolski (Lublin), J. Furmaga (Lublin), A. Jaroszyński (Lublin), S. Rudzki (Lublin), A. Wysokiński (Lublin)

11:00 - 12:30

The most frequent problems in patients with implanted devices

The most frequent problems in patients with implanted devices

Chairpersons: A. Kutarski (Lublin)
Chairpersons: B. Małecka (Kraków)

My patient after implantation of the device is pyrexial
B. Małecka (Kraków)

My patient after implantation of the device faints
P. Kułakowski (Warszawa, Rzeszów)

My patient after implantation of the device has palpitation
M. Chudzik (Łódź)

My patient after implantation of the device is awaiting surgical procedure
M. Sterliński (Warszawa)

Cardiac surgeon or cardiologist?

Cardiac surgeon or cardiologist?

Session under the patronage of the Centre for Rare Cardiovascular Diseases in Krakow

Chairpersons: P. Podolec (Kraków)
Chairpersons: P. Hoffman (Warszawa)
Chairpersons: J. Różański (Warszawa)
Chairpersons: A. Biederman (Warszawa)
Chairpersons: M. Kurzyna (Otwock)
Chairpersons: M. Roik (Warszawa)
Chairpersons: P. Pruszczyk (Warszawa)
Chairpersons: B. Kapelak (Kraków)

Endocarditis on reoperated aortic valve – a case and cardiologist's point of view
M. Komar (Kraków)

Endocarditis on reoperated aortic valve – cardiac surgeon's point of view
K. Widenka (Rzeszów)

Arrhytmias in an adult patient with single ventricle – a case and cardiologist's point of view
L. Tomkiewicz-Pająk (Kraków)

Arrhytmias in an adult patient with single ventricle – cardiac surgeon's point of view
S. Pawlak (Zabrze)

Patient with chronic thromboembolic pulmonary hypertension – a case and cardiologist's point of view
G. Kopeć (Kraków)

Patient with chronic thromboembolic pulmonary hypertension – cardiac surgeon's point of view
R. Przybylski (Zabrze)

Functional mitral regurgitation – diagnosis and treatment options

Functional mitral regurgitation – diagnosis and treatment options

Chairpersons: E. Straburzyńska-Migaj (Poznań)
Chairpersons: M. Krejca (Katowice)

Functional mitral regurgitation – echo assessment and prognosis
D. Kustrzycka-Kratochwil (Wrocław)

Functional mitral regurgitation – surgical treatment
M. Deja (Katowice)

Functional mitral regurgitation – percutaneous techniques
A. Gackowski (Kraków)

Old and new markers of cardiovascular disease. Is it worth to use them in everyday clinical practice?

Old and new markers of cardiovascular disease. Is it worth to use them in everyday clinical practice?

Chairpersons: P. Jankowski (Kraków)
Chairpersons: E. Płońska-Gościniak (Szczecin)

Central blood pressure and pulse wave velocity
P. Jankowski (Kraków)

Calcium score
C. Kępka (Warszawa)

IMT and other ultrasound techniques
Ł. Chrzanowski (Łódź)

CRP, uric acid, lipoprotein (a) and other soluble markers
A. Undas (Kraków)

Cardiology and pregnancy – the difficult art of interdisciplinary care of a mother and her baby

Cardiology and pregnancy – the difficult art of interdisciplinary care of a mother and her baby

Chairpersons: M. Demkow (Warszawa)
Chairpersons: O. Trojnarska (Poznań)

Heart failure In pregnancy
Z. Dzielińska (Warszawa)

Cardiac arrythmias In pregnancy
E. Biernacka (Warszawa)

Obstetric care in pregnant women with cardiac problems
M. Dębska (Warszawa)

USG and echocardiography in fetuses of women with cardiac problems
J. Szymkiewicz-Dangel (Warszawa)

Integrated cardiac care after myocardial infarction – it is high time to start making joint decisions

Integrated cardiac care after myocardial infarction – it is high time to start making joint decisions

Chairpersons: G. Opolski (Warszawa)
Chairpersons: J. Kaźmierczak (Szczecin)

Risk stratification after acute phase – significance of the personalised approach
M. Gąsior (Zabrze)

Antiplatelet treatment – how long and is it similar in all patients
M. Hawranek (Zabrze)

Revascularisation in acute coronary disease – how and when to qualify to a surgical procedure
J. Legutko (Kraków)

Implantable cardioverter-defibrillator – when and whether in all patients with reduction in the ejection fraction of the left ventricle
Z. Kalarus (Zabrze)

Cardiac rehabilitation following myocardial infarction – not for everyone?
R. Piotrowicz (Warszawa)

The status of interventional cardiology centres and ambulatory care in the model of the integrated health care system
D. Dudek (Kraków)

Atrial fibrillation Anno Domini 2016

Atrial fibrillation Anno Domini 2016

Chairpersons: T. Mularek-Kubzdela (Poznań)
Chairpersons: W. Wojakowski (Katowice)

Guidelines for anticoagulation in a patient with atrial fibrillation Anno Domini 2016
B. Wożakowska-Kapłon (Kielce)

Position of ablation in the treatment of patients with atrial fibrillation – whom refer to such treatment?
O. Kowalski (Zabrze)

When does my patient with atrial fibrillation requires the implantation of a pacemaker CRT-D/CRT-P/ICD?
P. Mitkowski (Poznań)

In which patient should we consider left atrial appendage closure?
M. Grygier (Poznań)

Best from ESC 2016 in Rome

Best from ESC 2016 in Rome

Session of the „Club 30”

Chairpersons: P. Burchardt (Poznań)
Chairpersons: R. Ochotny (Poznań)

Coronary heart disease
K. Kupczyńska (Łódź)

Non-invasive imaging techniques
B. Michalski (Łódź)

Heart failure and cardiomyopathies
P. Niewiński (Wrocław)

Electrotherapy
M. Mazurek (Zabrze)

Pulmonary hypertension
A. Budaj-Fidecka (Warszawa)

Preventive cardiology and hypertension
M. Haberka (Katowice)

Intensive cardiac care
A. Tycińska (Białystok)

Transcatheter aortic valve implantation (TAVI): where are we now? where are we going?

Transcatheter aortic valve implantation (TAVI): where are we now? where are we going?

Chairpersons: M. Jasiński (Katowice)
Chairpersons: A. Witkowski (Warszawa)

TAVI: changing paradigm in the years 2002–2016 as a result of randomized trials, registries and daily clinical practice
M. Tomala (Kraków), D. Dudek (Kraków)

TAVI and paravalvular leaks: did second-generation valves already solve this problem?
A. Ochała (Katowice)

How to avoid serious complications in TAVI?
K. Wilczek (Zabrze)

Who is a candidate for surgical approach in TAVI?
D. Jagielak (Gdańsk)

Are we ready to perform TAVI procedures in intermediate and low surgical risk patients?
A. Witkowski (Warszawa)

Imaging of selected cardiac muscle pathologies

Imaging of selected cardiac muscle pathologies

Chairpersons: T. Miszalski-Jamka (Kraków, Wrocław)
Chairpersons: Z. Gąsior (Katowice)

Viral myocarditis in patients with suspected acute coronary syndrome – the diagnostic value of cardiac magnetic resonance
M. Basiak (Katowice), M. Konopka (Katowice), T. Beck (Wiedeń), Ł. Bułdak (Katowice), E. Nowalany-Kozielska (Zabrze), B. Okopień (Katowice)

In the search of new diagnostic criteria of left ventricular noncompaction
M. Kubik, A. Dąbrowska-Kugacka (Gdańsk), M. Kutniewska-Kubik (Mała Piaśnica), K. Dorniak (Gdańsk), E. Lewicka (Gdańsk), L. Daniłowicz-Szymanowicz, D. Szalewska (Gdańsk), G. Raczak (Gdańsk)

Antracyclin-based chemotherapy and echocardiographic indices in patients with non-Hodgkin’s lymphoma
K. Mizia-Stec (Katowice), K. Wita (Katowice), M. Elżbieciak (Katowice), M. Wybraniec (Katowice), A. Bodys (Lublin), W. Braksator (Warszawa), Z. Gąsior (Katowice), P. Gościniak (Szczecin), T. Hryniewiecki (Warszawa), J. Kasprzak (Łódź), M. Różewicz (Warszawa), A. Wojtarowicz (Szczecin), E. Płońska-Gościniak (Szczecin)

The usefulness of echocardiography in diagnosing subclinical systolic and diastolic left ventricular dysfunction in Cushing's disease
B. Uziębło-Życzkowska (Warszawa), P. Krzesiński (Warszawa), P. Witek (Warszawa), G. Zieliński (Warszawa), G. Gielerak (Warszawa), A. Jurek (Warszawa), A. Skrobowski (Warszawa)

Cardiac magnetic resonance in patient with eosynophilic myocarditis
M. Basiak (Katowice), C. Wojciechowska (Zabrze), A. Gała (Zabrze), W. Jacheć (Zabrze), G. Helbig (Katowice), E. Nowalany-Kozielska (Zabrze)

Summary – rare cardiac muscle diseases – the imaging techniques I use
Z. Bilińska (Warszawa)

Challenging and atypical patients

Challenging and atypical patients

Chairpersons: L. Bryniarski (Kraków)
Chairpersons: T. Pawłowski (Warszawa)

A 19-year-old male patient with anterior wall STEMI, thrombocytosis and homocysteine transformations gene polymorphism
M. Falkiewicz (Lublin), B. Kondracki (Lublin), P. Waciński (Lublin), J. Kudlicki (Lublin), A. Wysokiński (Lublin)

Double thrombolysis in the early pregnancy can be safe
A. Kania (Lublin), J. Kudlicki (Lublin), A. Frania-Baryluk (Lublin), M. Trojnar (Lublin), A. Wysokiński (Lublin), P. Adamczyk (Lublin), E. Czekajska-Chehab (Lublin)

Staged percutaneous coronary intervention as a treatment of three-vessel coronary disease with left main coronary disease in a patient with congenital glucose-6-phosphate dehydrogenase deficiency
J. Wójcik (Lublin), M. Wójcik (Lublin), T. Zapolski (Lublin), M. Jankiewicz (Lublin)

Prosthetic valve endocarditis after transcatheter CoreValve Evolut R bioprosthesis implantantion
K. Zbroński (Zabrze, Warszawa), Z. Huczek (Warszawa), P. Ścisło (Warszawa), R. Wilimski (Warszawa), B. Rymuza (Warszawa), J. Kochman (Warszawa), K. Filipiak (Warszawa), G. Opolski (Warszawa)

Difficult questions – ambiguous answers?

Difficult questions – ambiguous answers?

Chairpersons: M. Wolszczak (Warszawa)
Chairpersons: Z. Kamińska (Warszawa)

Older female patients undergoing coronary angioplasty from radial approach require higher X-ray doses
P. Iwachów (Poznań), I. Miechowicz (Poznań), B. Dziki (Poznań), P. Kałmucki (Poznań), A. Szyszka (Poznań), A. Baszko (Poznań), T. Siminiak (Poznań)

Care for patients with implantable VAD
I. Copik (Zabrze), H. Pisarska (Zabrze)

Influence of vasovagal syncope on car driving and traffic safety
I. Bzukała (Kraków), A. Pietrucha (Kraków), J. Jędrzejczyk-Spaho (Kraków), E. Konduracka (Kraków), J. Nessler (Kraków)

Renovascular hypertension – new studies, new data

Renovascular hypertension – new studies, new data

Chairpersons: A. Januszewicz (Warszawa)
Chairpersons: A. Tykarski (Poznań)

Chronic consequences of kidney ischemia
. TBD

Atherosclerotic renal artery stenosis – management after CORAL study
M. Protasiewicz (Wrocław)

Fibromuscular dysplasia – related not only to renal arteries
A. Prejbisz (Warszawa)

Other, unappreciated causes of renovascular hypertension
E. Warchoł (Warszawa)

Legenda

Working Group Session
Session of clinical cases
Original papers session - oral presentations
Original papers session - moderated posters
Special Session
Satellite Session
Educational Session

Jubilee - 20 years in the eyes of the participants

 

Dear Sirs,

The XX International Congress of the Polish Cardiac Society is ahead of us. There have been implemented a lot of changes, also in the organizing process, since the I International Congress of the Polish Cardiac Society on September 4-6, 1997 took place. The abstract system, e-mails, mobile applications, online registration have gradually displaced paper registration forms, paper acknowledgements of receipt of an abstract as well as announcements and preliminary information in writing. Moreover, our conference rooms are more and more modern.

However, the main purpose of the meeting has remained unchanged for many years since power of our meetings lies within our excellent scientific program, exceptional people and an impressive attendance. The program and people have stood behind our success for twenty years.

We invite you to a sentimental journey. We present a unique gallery of participants and our scientific programs. Unfortunately, not all of them have been already found. In some cases, the cover of the program is replaced with printed announcements and information. Hence, we kindly ask you to send your conference keepsakes, missing covers, photos with brief notes about their content. We will create a wonderful gallery.     

Please, send the pictures on: ptk2016@casusmedical.pl

 

 

 

Programs

          
             
     
             
             
             
     
             
         

 

 

 People


Just before the I International Congress of the Polish Cardiac Society... 

 

 55. Kongres PTK, 15-17.09.1994 r., Poznań                            57. Kongres PTK, 31.08-1.09.1995 r. Warszawa  

 

 

VI Międzynarodowy Kongres PTK, 19-21.09.2002 r., Poznań

       

 

 

VIII Międzynarodowy Kongres PTK, 15-18.09.2004 r., Warszawa

       

 

 

       

 

 

XV Międzynarodowy Kongres PTK, 6-8.10.2011 r., Wrocław

       

 

 

       


XVI Międzynarodowy Kongres PTK, 20-22.09.2012 r., Poznań

       

 

 

       

 

XVII Międzynarodowy Kongres PTK, 26-28.09.2013 r., Wrocław

       

 

 

       

 

Kontakt

Kontakt z Komitetem Organizacyjnym – pakiety sponsorskie, wystawcy:
kongres2016@ptkardio.pl



Kontakt w sprawie rejestracji indywidualnej i grupowej:
kongres2016@casusMEDICAL.pl

Certificates

Within three days after the conclusion of the Congress, the participants will receive a certificate of participation in the Congress in PDF file onto the e-mail address indicated during registration. The certificates will be also available to download in PDF file directly from the Congress website(tab 'Certificates').

Certificates in paper form will not be issued.

Główny Sponsor Kongresu

boehringer-ingelheimservier

Sponsorzy Kongresu

polpharma

Sesje Satelitarne Kongresu

abbottAmegenAstraZenecaBerlin chemieBiofarmIMPULSE DynamicsKRKAMSDNOVARTISPfizerSANDOZSiemens

Patronat Medialny

Forum MediaIAKardiologia PolskaMEDtubeMedycyna praktycznaOPMPuls MedycynyPZWLŚwiat Medycyny i Farmacji Terapia